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ABSTRACT OF THE DISSERTATION  
THE INFLUENCE OF PSYCHOLOGICAL PREDICTORS AND COGNITIVE 
BEHAVIORAL STRESS MANAGEMENT INTERVENTION ON 
ANTIRETROVIRAL THERAPY (ART) ADHERENCE AMONG HIV-POSITIVE 
FEMALE HAITIAN ALCOHOL USERS 
by 
Pascale Cecile Jean 
Florida International University, 2015 
Miami, Florida 
Professor Jessy G. Dévieux, Major Professor  
Purpose:  Over half the HIV-infected persons in the Caribbean, the second most HIV-
impacted region in the world, live in Haiti. Using secondary data from a parent study, this 
research assessed the effects of psychological and social factors on antiretroviral therapy 
(ART) adherence among Haitian, HIV-positive, female alcohol users.  
Theoretical Foundation and Research Questions: Using the Theory of Planned 
Behavior/Reasoned Action and the Information, Motivation, Behavior skills model as 
guiding theoretical frameworks, the study examined the effectiveness of an adapted 
cognitive behavioral stress management (CBSM-A) intervention in improving ART 
adherence. The effect of psychological factors (depression, anxiety, beliefs about 
medicine, and social support), social factors (stigma, relationship status, and educational 
attainment), and alcohol on adherence to ART was assessed.  
Methods: The sample consisted of 116 female ART patients who were randomly assigned 
to the CBSM-A intervention or the wait-list control group. Participants completed 
 vi 
 
intervention sessions as well as pre- and post-test assessments. Analyses of variance, t-
tests, and point biserial correlations were used to test hypotheses.  
Results: Surprisingly, ART adherence rates significantly decreased for both groups 
combined [F (1, 108) = 8.79, p = .004]; there was no significant difference between the 
intervention and control groups with regard to the magnitude of change between baseline 
and post assessment. On average, depression decreased significantly among participants 
in the CBSM-A group only [(t (62) = 5.54, p < .001)]. For both groups combined, alcohol 
use significantly decreased between baseline and post-assessment [(F (1, 78) = 34.70, p < 
.001)]; there was no significant difference between the intervention and control groups 
with regard to the magnitude of change between baseline and post-assessment. None of 
the variables were significantly correlated with ART adherence. 
Discussion: Adherence to ART did not improve in this sample, nor were any of the 
variables significantly associated with adherence. The findings suggest that additional 
supportive and psychological services may be needed in order to promote higher 
adherence to ART among HIV-positive females. More research may be needed on this 
sample; a focus on mental health issues, partner conflict, family and sexual history may 
allow for better targeting and more successful interventions.  
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CHAPTER I 
INTRODUCTION 
Haiti shares the island of Hispaniola with the Dominican Republic. Haiti is the 
third largest Caribbean nation, after Cuba and the Dominican Republic; it is known for 
being the first independent nation in the Americas, the only republic born of a successful 
slave revolt, and the first black-led republic in the world since 1804 (CIA World Fact 
Book, 2013; World Book Encyclopedia, 1996). Haiti is the poorest country in the 
Western Hemisphere and among the poorest in the world. Haiti ranks 161st of 187 
countries in the Human Development Index (HDI) and has limited resources to meet its 
citizens’ basic needs (UN Development Programme, 2013; World Bank- Haiti, 2014). 
Haiti is estimated to have a population of approximately 10 million inhabitants, just under 
a million of whom live in the capital city, Port-au-Prince; Haiti’s large population 
coupled with its deficient infrastructure make the country particularly vulnerable to the 
effects of natural disasters (WHO, 2011). Over half of its population lives on less than 
U.S. $1 per day, and approximately 80% live on less than U.S. $2 per day (World Bank- 
Haiti, 2014).  
Haiti and HIV/AIDS. There are numerous health issues that affect the lives of 
people living in Haiti. These health issues are fueled by rampant poverty and high 
illiteracy rates, as high as 48.7% in 2008-2012 (UNICEF, 2009; WHO, 2013).  
Additionally, inadequate social services have deteriorated due to an unstable political 
government; a devastating earthquake and the first cholera epidemic in the Caribbean in 
over 100 years (Charles et al., 2014; Pape, Johnson, & Fitzgerald, 2010); high migration 
rates and high prevalence of sexually transmitted diseases have also contributed to 
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numerous health issues (WHO, 2013). Haiti has the highest rates of under-five, infant and 
maternal mortality in the Western Hemisphere (CIA World Fact Book, 2013; UNICEF, 
2009). Diarrhea, malaria, tuberculosis and HIV/AIDS are the leading causes of death 
among the population (UNICEF, 2009; WHO, 2013; AIDS Healthcare Foundation, 
2014). Haiti also has the second highest prevalence of HIV in Latin America and the 
Caribbean and the highest number of people living with HIV/AIDS in the region 
(UNAIDS Global Report, 2013; UNAIDS Fact Sheet, 2012). The epidemic, which began 
in the late 1970s, has spread widely across the country (AIDS Healthcare Foundation, 
2014). Haiti not only faces the worst AIDS epidemic outside of Africa but also bears the 
greatest burden of HIV infection in the Western Hemisphere (AIDS Healthcare 
Foundation, 2014).  
Women and HIV.  Although data show a decrease in the proportion of women 
living with HIV over the last 10 years, the latest World Health Organization (WHO) and 
UNAIDS global estimates reveal that women comprise 50% of People Living with HIV 
(PLWH) worldwide (UNAIDS Global Report, 2013). The latest HIV and AIDS data from 
Haiti indicate that 74,000 women (aged 15 and older) are living with HIV, which 
represents 52% of the 130,000 adults (aged 15 and older) living with HIV (AIDS 
Healthcare Foundation, 2014; UNAIDS Fact Sheet, 2012; CDC HIV among Women, 
2013). Worldwide, the WHO reports that there are a number of key drivers of HIV 
incidence and adherence to antiretroviral therapy (ART) in women associated with 
gender inequalities. Several of these key factors are gender norms, gender-related barriers 
in access to services, the far greater efficiency of HIV transmission from male to female 
partners during penile-vaginal sex, women assuming the major share of caregiving, and 
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lack of education and economic security (UNAIDS Global Report, 2013; WHO 
Department of Gender, Women and Health, 2013; Nicolosi et al, 1994). Additional 
information regarding women and HIV will be discussed in the literature review in the 
following chapter.  
Treatment Adherence. There are several key components included in all 
successful HIV/AIDS treatment programs; one of the most important variables that 
influences the success of these programs is the level of adherence to ART. According to 
the WHO, standard ART consists of at least three antiretroviral drugs from at least two 
classes that not only maximally suppress the HIV virus but also stop the progression of 
the disease (WHO, 2014). Current WHO recommendations include using ART for HIV 
prevention, especially in pregnant women and other vulnerable populations (WHO, 
2014). Some research indicates that, depending on the ART regimen, from 80% to as 
much as 95% adherence may be necessary to achieve optimal clinical, virologic, and 
immunologic outcomes (Lucas, 2005; Kobin & Sheth, 2011; Bangsberg et al., 2001).  
Optimal ART adherence has multiple benefits, among them suppressing viral 
replication, rendering viral levels undetectable in blood, sexual fluids, and most 
importantly, reducing risk of progression to opportunistic infections and death HIV 
transmission (White House Office of National AIDS Policy, 2010; White House Office 
of National AIDS Policy, 2013; Cohen et al., 2011). ART has played a significant role 
not only in reducing mortality and improving the quality of life of persons living with 
HIV, but also in helping them achieve long-term optimal health and almost certainly in 
reducing HIV incidence (UN Development Programme, 2013; Donnell et al., 2010; 
Palombi et al., 2012; Paterson et al., 2000; Bangsberg, Moss, & Deeks, 2004; Carpenter 
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et al., 1997; UNAIDS HIV and AIDS Estimates, 2014). Conversely, inadequate ART 
adherence is associated with increased risk of progression to AIDS, mortality, emergence 
of viral resistance, and higher risk of transmission (Donnell et al., 2010; Palombi et al., 
2012; Paterson et al., 2000; Bangsberg et al., 2004; Carpenter et al., 1997; UNAIDS HIV 
and AIDS Estimates, 2014). 
Haiti and ART.  In 2012, more than 9.7 million people living with HIV were 
receiving ART in low and middle-income countries (UNAIDS Global Report, 2013; 
CDC, 2013; CDC HIV among Women, 2013). In Haiti, it is estimated that the number of 
people with HIV is 130,000 adults. However, only 63% of those who needed it were 
receiving ART in 2012 (CIA World Fact Book, 2013; World Bank, 2014). The latest HIV 
and AIDS data from Haiti indicate that 74,000 of persons living with HIV/AIDS are 
women aged 15 and older; 13,000 children aged 0 – 14 years are living with HIV (World 
Bank, 2014), of whom 6,700 require ART, while only 34% receive it (UNAIDS Global 
Report, 2013). The number of deaths attributed to HIV declined from 15,000 in 2001 to 
6,400 in 2014 (CIA World Fact Book, 2013; World Bank, 2014). The adult prevalence 
rate is estimated to be between 1.8% and 2.1% (UNAIDS Global Report, 2013; CDC, 
2013; CDC HIV among Women, 2013; World Bank, 2014).  
Recent studies have found varying adherence rates among individuals, reporting 
that between 18% - 73% of participants are non-adherent (Bangsberg et al., 2004; Cats et 
al., 2000; Tesoriero et al., 2003; Purcell et al., 2004; Castro 2005; Wood et al., 2009). 
Study findings further indicate that even lower adherence rates can be found in PLWH 
who are also dealing with substance abuse and/or environmental and psychological 
constraints, including the formidable challenges endured by Haitians with HIV infection 
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since the 2010 earthquake (Wood et al., 2009; Malow et al., 2010; Moatti, 2002; Safren et 
al., 2001; Koenig et al., 2010). Research has identified multiple barriers to ART 
adherence and response, including poor social support (Dévieux et al., 2009; Malow, 
Rosenberg, & Dévieux, 2009; Bryant, 2006), alcohol abuse (Samet et al., 2004; Baum et 
al., 2010; Malow et al., 2013; Nachega et al., 2005), negative beliefs about medicine 
(DiMatteo, Lepper, & Croghan, 2000; Starace et al., 2002), depression and anxiety 
(Dévieux et al., 2009;  Starace et al., 2002; Weaver et al., 2005; Krain & Fitzgerald, 
2005; Ghose et al., 2013), and stigma (Castro & Farmer, 2005; Dévieux et al., 2004; 
Vyavaharkar et al., 2007). 
 
Psychological Factors Associated with ART Adherence.   
 Psychological variables, such as social support, when at optimal levels, are 
conceptualized as tools that not only help deal with stress but also may contribute to 
positive health outcomes. It is suggested that HIV-infected women who have access to 
resources, such as social support, are more likely to effectively manage stressful 
situations and less likely to have poor outcomes (Hudson et al., 2001). Furthermore, 
researchers and experts in the field have indicated that social support from family, 
friends, and/or healthcare professionals has been found to diminish depressive symptoms 
among HIV positive individuals (Lazarus & Folman, 1984). Conversely, individuals with 
less social support are less able to cope with the challenges related to HIV and experience 
more negative outcomes (Cox, 2002). Numerous studies have examined the association 
between perceived social support and ART adherence and have found emotional support 
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to be a significant predictor of medication adherence and adherence treatment (Gordillo 
et al., 1999; Neame & Hammond, 2005; Riekert & Drotar, 2002). 
Belief about Medicines. Belief and attitude about illness correlate strongly with 
treatment adherence in other chronic diseases (Reynolds et al., 2004; Dilorio et al., 2009; 
Tyler-Viola et al., 2014). According to the health belief model, two major factors 
influence the likelihood that individuals will adopt recommended regimens: 1) they must 
feel susceptible to the serious or severe consequences of the disease, and 2) they must 
believe that the benefits of taking the preventive action outweigh the perceived barriers 
(Johnson et al., 2006). Studies focusing on the factors influencing medication adherence 
beliefs and self-efficacy in persons naïve to ART deduced that a greater belief in one’s 
ability to adhere to ART and higher confidence in its benefits were associated with higher 
quality of life (Johnson et al., 2006; Horne & Weinman, 1999). Other studies have found 
that adherence, self-efficacy, and depression symptoms predicted ART adherence (Horne 
& Weinman, 1999; Horne, Weinman, & Hankins, 1999; UNAIDS Report on Global 
AIDS Epidemic, 2010). People with weaker beliefs about the necessity to adhere to 
medication treatment and those with higher levels of concern about the medications are 
more likely non-adherent (Sowell & Phillips, 2010; Katz et al., 2013).  
Depression and anxiety have been associated with non-adherence to ART 
(Bryant, 2006; Dévieux et al., 2009; Baum et al., 2010; Malow et al., 2013; Nachega et 
al., 2005; Li et al., 2011). A study examining behavioral and social factors that predict 
medication adherence found that poor ART adherence was significantly predicted by 
avoidant coping, which is predicted by both lack of social support and negative mood 
states (DiMatteo, Lepper, & Croghan, 2000). Similar links between mood and adherence 
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have been found in other studies (Bryant, 2006; Nachega et al., 2005; Starace et al., 2002; 
Weaver et al., 2002). Thus, multivariable investigation of the correlation between 
psychological variables, such as depression and anxiety and ART adherence, may be 
needed, particularly among high-risk groups such as alcohol users (Donnell et al., 2010; 
Li et al., 2011).  
 
Social Factors Associated with ART Adherence.   
Perceived stigma can lead to discrimination, shame, and fear. Studies have found 
that the fear of negative social consequences frequently causes HIV-positive individuals 
to keep their status secret, often resulting in negative psychological and physical 
outcomes and continued HIV transmission (Sowell & Phillips, 2010; Katz et al., 2014; 
Ansari & Gaestel, 2010; Li et al., 2011; Malow et al., 2000). Thus, stigma is a challenge 
when treating and caring for persons with HIV infection. The fear associated with being 
stigmatized may cause individuals to avoid care and services (Cox, 2002; Fawzi et al., 
2010; DeSantis, Thomas, & Sinnett, 1999; Arrivillaga et al., 2011; Do et al., 2010). This 
fear is also associated with the lack of protective behaviors such as adherence to ART 
(Fawzi et al., 2010; DeSantis et al., 1999; Arrivillaga et al., 2011; Do et al., 2010). 
Additional studies have found that stigma may be especially problematic for women, as it 
can limit their marital prospects, constrain their participation in community, household 
and family roles, and diminish their quality of life (Do et al., 2010; Mills et al., 2006; 
Lillard & Panis, 1996; Smith & Waitzman, 1994; Bourne, 2009; Waldron, Hughes, & 
Brooks, 1996; Ross, Mirowsky, & Golsteen, 1990). 
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Relationship Status. Studies have found that married individuals have a better 
self-reported health status and/or lower mortality than non-married people (Ross et al., 
1990; Macintyre, 1992; McKenzie, 1993). In most studies, married adults also have lower 
morbidity and better physical health than unmarried adults (St. Bernard, 2003; AIDS 
Control and Prevention, 1996; Byakika-Tusiime et al., 2005). In the Caribbean sub-
region, the percentage of formal marriage and common-law unions has remained constant 
(DeWalt et al., 2004). Although common law and visiting unions have been traditionally 
associated with individuals from a lower socio-economic status group, the prevalence of 
common-law unions has increased among women from middle and higher socio-
economic groups in Caribbean societies (Kilian et al., 1990; Hargreaves & Glynn, 2002). 
Research found that the union status of women may be considered as a proxy for 
exposure to sexual intercourse and by extension, their risk of childbearing and prevalence 
of sexually transmitted infections (Hargreaves & Glynn, 2002; Nachega et al., 2004). 
Although marital status and/or companionship is related to lower mortality, marital status 
has been associated with low adherence to ART, especially in countries with high 
prevalence of HIV/AIDS (Nachega et al., 2004; Orrell et al., 2003). 
Educational Attainment. Among the main methods to reduce the prevalence and 
transmission of HIV in heterosexual transmission is behavior change. Behavior change 
may be associated with educational level (Weidle et al., 2002). Increased educational 
attainment may improve the ability to understand and act on health promotion messages, 
though some studies call this into question (Weidle et al., 2002; Laurent et al., 2002). For 
example, in a study conducted in Soweto, South Africa, 66 participants were studied 
(71% were women and 79% had completed high school or some advanced educational 
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training) (Smith, El Obeid, & Jensen, 2000). The study concluded that despite the low 
socioeconomic status, and low-to-mid levels of educational attainment of the population, 
88% reported 95% adherence to ART (Smith et al, 2000). The study concluded that the 
high adherence levels observed may be due to the increased motivation of South Africans 
who know that drugs are scarce and who have witnessed and have been exposed to the 
negative effects of untreated HIV/AIDS (Smith et al., 2000). Similar results regarding 
education attainment’s role in ART adherence were also found from cohorts in South 
Africa, Senegal and Uganda (Orrell et al., 2003; Weidle et al., 2002; Laurent et al., 2002; 
Smith et al., 2000). 
 
Value of the Research  
Findings on the impact of psychological and social factors on ART adherence 
among HIV-positive female Haitians may contribute to the direction of future research 
and practice. Outcomes from this study may be informative in guiding implementation of 
an effective intervention, such as CBSM-A, to improve adherence. The target population, 
HIV-positive female Haitians, has the second highest HIV prevalence and death rates 
from HIV/AIDS in the Caribbean (WHO, HIV/AIDS Fact Sheet, 2014; World Bank, 
2014; UNAIDS Report on Global AIDS Epidemic, 2010). This research assessed the 
relationship between psychological factors (depression, anxiety, beliefs about medicine, 
and social support) and adherence to ART among Haitian HIV-positive female alcohol 
users. The present study also examined the role of stigma, relationship status and 
educational attainment on adherence to ART. Outcomes from this study may contribute 
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to the growing body of knowledge on this understudied group of Haitian HIV-positive 
female alcohol users.  
 
Proposed Study 
Using secondary data from the parent study, this dissertation examined the short-
term effectiveness of the Cognitive Behavioral Stress Management – Adapted (CBSM-A) 
intervention on improving ART adherence in a female, HIV+ sample of alcohol users. 
This dissertation aims to identify relationships among measures of social support, beliefs 
about medicines, depression and anxiety, and alcohol use severity in predicting adherence 
to antiretroviral medications. In addition to examining the psychological predictors, this 
dissertation also examined the role of perceived stigma, relationship status, and 
educational attainment on adherence to ART. See Figure 1 below for a schematic 
conceptualization of the research. 
Figure 1. Conceptual model of CBSM-A intervention effects moderated by 
psychological factors, alcohol use, and social factors  
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Research questions/hypotheses  
Research Question 1:  Is the Cognitive Behavioral Stress Management – Adapted 
(CBSM-A) intervention effective in improving ART adherence among HIV-positive 
Haitian female alcohol users?  
Hypothesis #1: Female participants in the CBSM-A group will show better ART 
adherence than those in the wait-list control group. 
Null Hypothesis #1: Female participants in the CBSM-A group will not show 
better ART adherence than those in the wait-list control group. 
 
Research Question 2: Are the psychological factors —social support, depression, anxiety, 
and beliefs about medicine—associated with ART adherence at baseline and post-
assessment among HIV-positive Haitian female alcohol users in the intervention group? 
Research Question 3: Do psychological factors —social support, depression, anxiety, and 
beliefs about medicine— improve from baseline to post-assessment among HIV-positive 
Haitian female alcohol users at the end of the intervention? 
Hypothesis #2a:  Social support will be directly related to ART adherence among 
HIV-positive Haitian adult females. 
Null Hypothesis #2a: Social support will not be related to ART adherence among 
HIV-positive Haitian adult females. 
Hypothesis #2b: Social support will improve among HIV-positive Haitian adult 
females at the end of the intervention. 
Null Hypothesis #2b: Social support will not improve among HIV-positive 
Haitian adult females at the end of the intervention. 
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Hypothesis #3a: Depression and anxiety will be inversely correlated with ART 
adherence among HIV-positive Haitian adult females.   
Null Hypothesis #3a: Depression and anxiety will not be inversely correlated with 
ART adherence among HIV-positive Haitian adult females.   
Hypothesis #3b: Depression and anxiety will improve among HIV-positive 
Haitian adult females at the end of the intervention. 
Null Hypothesis #3b: Depression and anxiety will not improve among HIV-
positive Haitian adult females at the end of the intervention. 
Hypothesis #3c: Patients randomized to CBSM-A will have lower depression and 
anxiety scores at post-assessment than those assigned to wait-list control group. 
Null Hypothesis #3c: Patients randomized to CBSM-A will not have lower 
depression and anxiety scores at post-assessment than those assigned to wait-list 
control group.  
Hypothesis #4a: High beliefs in the value of medicines will be positively 
associated with ART adherence among HIV-positive Haitian adult females.  
Null Hypothesis #4a: High beliefs in the value of medicines will not be positively 
associated with ART adherence among HIV-positive Haitian adult females.  
Hypothesis #4b: Beliefs in the value of medicines will improve among HIV-
positive Haitian adult females at the end of the intervention 
Null Hypothesis # 4b: Beliefs in the value of medicines will not improve among 
HIV-positive Haitian adult females at the end of the intervention 
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Research Question 4: Do the social factors— perceived stigma, relationship status and 
educational attainment—affect ART adherence among HIV-positive Haitian female 
alcohol users?  
Hypothesis #5: Perceived stigma will be inversely related to ART adherence 
among HIV-positive Haitian adult females.  
Null Hypothesis #5: Perceived stigma will not be inversely related to ART 
adherence among HIV-positive Haitian adult females.  
Hypothesis #6: Participants in a relationship will have higher adherence than 
those not in a relationship. 
Null Hypothesis #6: Participants in a relationship will not have higher adherence 
than those not in a relationship. 
Hypothesis #7: Participants with lower educational attainment will have lower 
ART adherence values. 
Null Hypothesis #7: Participants with lower educational attainment will not have 
lower ART adherence values. 
 
Research Question 5: Does the degree of alcohol abuse affect ART adherence among of 
HIV-positive Haitian female alcohol users? 
Research Question 6: Does the degree of alcohol abuse change between baseline and 
post-assessment in response to the intervention among of HIV-positive Haitian female 
alcohol users?   
 14 
 
Hypothesis #8a: Alcohol use will decrease among HIV-positive Haitian adult 
females at the end of the intervention. 
Null Hypothesis #8a: Alcohol use will not decrease among HIV-positive Haitian 
adult females at the end of the intervention. 
Hypothesis #8b: Greater alcohol use severity will be associated with lower ART 
adherence among HIV-positive Haitian adult females. 
Null Hypothesis #8b: Greater alcohol use severity will not be associated with 
lower ART adherence among HIV-positive Haitian adult females. 
 
The next chapter will review past and current literature on the subjects relevant to 
the research questions mentioned above, the psychological 
 factors, such as depression and anxiety, beliefs about medicine, and social 
support as they relate to adherence to ART. In addition, the role of perceived stigma, 
relationship status, and educational attainment will be reviewed.  
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CHAPTER II 
LITERATURE REVIEW 
The following literature review is organized into three distinct sections that focus 
on the scope of the problem and the major research questions. The three sections are 
theoretical foundations, Cognitive Behavior Stress Management, and psychological and 
social factors affecting adherence to ART. These three sections are presented in a logical 
approach to demonstrate the context, process, and content of the research study. A 
detailed review of the literature has been completed in each area, and trends are 
discussed.  
 
Theoretical Foundations 
 This study examined the psychological factors associated with ART adherence 
among HIV-positive adult female Haitian alcohol users as well as the effectiveness of the 
adapted Cognitive Behavioral Stress Management Intervention in improving ART 
adherence. Multiple theoretical foundations were considered for the theoretical 
framework. Since the focus is on individual behavior and effectiveness of the 
intervention, the Theory of Planned Behavior/Reasoned Action and the Information 
Motivation Behavioral (IMB) Skills Model were selected. The parent study’s adapted 
intervention was based on a National Institutes of Health (NIH) funded pilot study in 
Haiti, which was guided by the IMB skills model. 
Theory of Planned Behavior/Reasoned Action- This theory is an individual-
oriented theory which initially was named the Theory of Reasoned Action and later 
revised to the Theory of Planned Behavior. The Theory of Planned Behavior/Reasoned 
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Action (TPB/TRA) represents a theoretical framework which identifies the relationship 
between attitude and behavior (Ajzen, 1991; Ajzen, 1980; Edberg, 2007). This theory 
focuses on rational, cognitive decision-making processes, which include:  
1) Attitude –  
a. an individual’s beliefs about what will happen if they perform the 
behavior;  
b. an individual’s judgment of whether the expected outcome is positive or 
negative.  
2) Subjective Norms –  
a. an individual’s beliefs about what other people in their social group will 
think about the behavior;  
b. an individual’s motivation to conform to the perceived norms.  
3) Behavioral Intention –  
a. an individual’s intention to perform a behavior.  
4) Perceived Behavior Control – separated in two parts:  
a. Control beliefs – an individual’s beliefs about factors that will make it 
easier or more difficult to perform the behavior  
b. Perceived Power – the amount of power an individual believes they 
have over performing the behavior (Ajzen, 1991; Ajzen, 1980; Edberg, 2007; 
Montana & Kasprzyk, 2002; Armitage & Conner, 1999; Hausmann-Muela, Muela 
& Nyamongo, 2003).  
The fourth process, perceived behavior control, mentioned above was added to TRA, 
which led to the name change of the TPB.  One of the most important aspects of the TPB 
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is the focus placed on the role of social support and feelings of self-control and self-
efficacy (MacKian, 2003). Illustration of the TPB/TRA theory is outlined in Figure 2 
(Edberg, 2007). 
 
Figure 2. Schematic representation of Theory of Planned Behavior/Reasoned Action 
 
 
 
 
 
 
  
 
 
 
 Theory of Planned Behavior/Reasoned Action and Adherence. The TPB has 
been applied to multiple studies focusing on health-related behaviors and medication 
adherence (MacKian, 2003; Vissman, et al., 2011) and used extensively in HIV/AIDS 
research and programs (Kagee, 2008). Several researchers, including Hausmann-Muela et 
al. and Armitage and Corner (Hausmann-Muela, Muela, & Nyamongo, 2003; MacKian, 
2003), have hailed the TPB for taking into consideration not only the motivational 
aspects of personal control, but also the role of social networks and peer pressure in 
health behavior. Other studies’ findings applied the theoretical concepts of TPB in 
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identifying factors to enhance adherence in underprivileged populations (Kagee, 2008; 
Harderman et al., 2002). While TPB has been found to have had promising (but not 
conclusive) results regarding the effectiveness of the theory’s components (Armitage & 
Conner, 2001; Godin & Kok, 1996; Munro et al., 2007), it has been criticized by some 
researchers for not placing emphasis on structural and social factors, such as religious 
beliefs, stigma associated with diseases like HIV/AIDS, and availability of resources 
(Sutton, 1997; Noar & Zimmerman, 2005). By examining many psychological and social 
factors and attempting to determine which have a significant impact on ART adherence, 
this study hopes to add to the literature to clarify which variables have an effect on 
outcomes. 
 Cognitive processes are presumed to guide health behaviors, such as adherence to 
medication, and have been extensively associated with research focused on health 
behavior. TRA/TPB is one of the theories that has been utilized due to its focus on 
attitudinal beliefs, self-efficacy, and normative and norm-related beliefs and activities 
(Parsons, Rosof, & Mustanksi, 2008; Parsons, Rosof, & Mustanksi, 2007). There are 
multiple studies that have shown some connections between effective medication 
adherence and self-efficacy (Parsons et al., 2007; Ammassari et al., 2002). Similar studies 
have found that patients who believe they are capable of taking their medications (self-
efficacy) are more likely to be adherent (Ickovics et al., 2002; Molassiotis et al., 2002; 
Wagner et al., 2002). Other studies have found that those who also believe in the 
effectiveness of the ART medication were more likely to be adherent (Fisher & Fisher, 
1992). Therefore in the current study, perceived behavioral control will refer to specific 
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psychological and social factors that individuals may or may not have control over and 
the effects of perceived behavioral control on adherence to ART. 
Information Motivation Behavioral Skills (IMB) Model. There are multiple 
models of health behavior change that have been developed to understand the factors that 
influence HIV transmission, prevention, and treatment. The IMB Model is one theoretical 
framework that has effectively predicted HIV risk and preventive behavior in diverse 
populations and conditions (Amico, Toro-Alfonso, & Fisher, 2005; Fisher et al., 2006). 
This model, although constructed to be malleable and simple (Sutton, 1997; Fisher & 
Fisher, 2006), has been tailored specifically to designing interventions that promote 
adherence to ART (WHO, 2003). The IMB model focuses on three components that 
result in behavior change: 1) information – relates to the basic knowledge about the 
conditions and associated recommendations; 2) motivation – personal attitudes towards 
adherence, perceived social support, and the individual’s subjective norm; and 3) 
behavioral skills (including factors such as tools and self-efficacy) – the belief that they 
can achieve the behavior (Fisher et al., 2006). An illustration of the IMB model is 
outlined in Figure 3 (Amico et al., 2005; Fisher et al., 2006; Fisher et al., 2008). 
Figure 3. Information Motivation Behavioral Skills Model 
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Information Motivation Behavioral Skills (IMB) Model and Adherence. The 
IMB model proposes that ART regimen and its side effects, including attitudes and 
beliefs about adherence and non-adherence, will eventually influence adherence-related 
health behavior (WHO, 2003). Although several empirical studies have established the 
strength of the IMB model’s three major components in predicting ART adherence 
(Fisher et al., 2006; Starace et al., 2006; Kalichman et al., 2002), it is suggested that the 
components of the model are usually generalizable when applied to a well-defined 
population (Kalichman et al., 2005) and require more specific measurable variables 
(Amico et al., 2009). Other reviews have concluded that the IMB model has not 
consistently resulted in an accurate prediction of adherence, especially when it comes to 
defining and measuring the motivation portion of the model (Rongkavilit et al., 2010; 
Schneidermna, Antoni, & Ironson, 2014). The results of this study will add further 
clarification when the IMB model is associated to ART adherence, especially in an 
understudied population.  
The use of the IMB model along with the TPB/TRA will offer valuable input into 
the scope and use within this particular population: Haitian, HIV-positive, female alcohol 
users, who have low socioeconomic status, have low-to-middle education level and also 
reside in and receive care in Haiti. The fact that both TPB/TRA and IMB models have 
been used in such varied populations to improve adherence demonstrates their versatility 
and appropriateness for the current study. In this study, the adherence to ART was 
examined in conjunction with perceived stigma, belief about medicine, social support, 
level of depression and anxiety, and level of alcohol abuse. 
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Cognitive Behavioral Stress Management (CBSM)  
Due to the recent advances in treatments and therapies, HIV/AIDS which was 
once viewed as a universally terminal disease, has become a chronic disease for ART 
patients, in which adherence to ART is a key component. Based on the theoretical 
foundation outlined in the previous section, the use of a psychological intervention 
technique, such as Cognitive Behavioral Stress Management (CBSM), is a good fit for 
use in this study. CBSM is a short-term therapeutic approach that concentrates on how 
people’s emotions and behaviors are affected by their thoughts (Kelly & Kalichman, 
2002). CBSM protocols provide opportunity to build individuals’ emotional and 
interpersonal skills (Kelly & Kalichman, 2002). According to research, since patient self-
management is so important, psychological interventions focusing on stress management 
have become effective components of successful HIV management and treatment (Kelly 
& Kalichman, 2002; Crepaz et al., 2008). CBSM’s goals are to influence irrational 
thoughts while focusing on finding and shifting behaviors and thought patterns. CBSM 
protocols provide opportunities for psychologists to provide information, build emotional 
and interpersonal skills, and also provide support throughout the process. During CBSM 
therapy, individuals learn recovery skills that are useful throughout their lifetimes (Brown 
& Vanable, 2008; Berger et al., 2008; Linden, 2004). An outline of the CBSM training 
sessions is presented in Figure 4 (Ironson & Hayward, 2008). 
Figure 4. Subject and outlines of Cognitive Behavioral Stress Management training 
sessions 
 
Session Outline 
First Introduction, group member greeting, explaining group rules, time and 
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number of sessions, concept of stress, conducting pre-tests, giving 
homework 
Second 
Reviewing the previous session homework, educating the group about the 
causes and outcomes of stress, how to manage stress, teaching relaxation 
techniques with practical exercise, homework 
Third 
Reviewing the previous session’s homework, introduction to automatic 
thought, role of thought in causing stress, association of thoughts with 
emotions and behavior, how to manage thoughts 
Fourth Challenging participants with thoughts and illogical beliefs 
Fifth Teaching communication skills, self-expression and self-confidence 
Sixth 
Practicing the already learned skills from past sessions, implications of 
these skills in stressful situations, conducting post-tests 
Seventh Teaching time management and planning activities 
Eighth 
Reviewing of already learned skills, answering the questions, conducting 
post-tests 
 
Cognitive Behavioral Stress Management (CBSM) and Adherence. Multiple 
studies, which have conceptualized HIV as a chronic disease, have utilized group-based 
CBSM to improve quality of life and slow symptom onset for those infected with HIV. 
Findings from multiple research studies (Dévieux et al., 2009; Kelly & Kalichman, 2002; 
Crepaz et al., 2008; Brown & Vanable, 2008) showed that CBSM can improve the 
individual’s quality of life by decreasing the distress and depressed affect associated with 
having a chronic and likely terminal disease. Additionally, by utilizing CBSM 
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techniques, the use of acceptance and positive reframing strategies would inherently lead 
to increased, or maintained, social support. The studies also show that psychological 
intervention facilitates adherence to good health practices and appropriate utilization of 
the health care system. This transpires by decreasing the use of maladaptive coping 
strategies, such as avoidance and denial, and instead using more problem-focused 
strategies. Additionally, the studies suggest that CBSM intervention, including relaxation 
training, is able to attenuate the impact of stressors upon an already compromised 
immune system and in doing so, might slow the course of immune decline that is detected 
in PLWH (Dévieux et al., 2009; Kelly & Kalichman, 2002; Crepaz et al., 2008; Brown & 
Vanable, 2008).  
As indicated by the IMB model, these techniques and skills learned throughout 
the CBSM process help improve quality of life by facilitating adherence to medication, 
decreasing isolation and depressive symptoms as well as improving immune function 
(Rosenberg et al., 2009; Kelly & Kalichman, 2002; Crepaz et al., 2008; Brown & 
Vanable, 2008; Berger et al., 2008; Ironson & Hayward, 2008). The CBSM process 
targets the individual’s relationship between attitude and behavior, as theorized by the 
TPB/TRA as well as the motivation and behavior skills’ components of the IMB model. 
Collective research has shown that the use of CBSM therapy has had a significant role in 
the management of HIV. CBSM therapy includes reducing distress, improving adherence 
to ART, and facilitating the efforts of HIV-infected individuals in improving quality and 
quantity of life. Inversely, poor coping strategies were associated with increased 
morbidity and mortality risks, which contributed to adherence issues and missed medical 
appointments (Catz, Gore-Felton, & McClure, 2002; Talam et al., 2008). 
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          Cognitive Behavioral Stress Management-Adapted (CBSM-A). In the parent 
study, CBSM-A was based on an NIH funded pilot study in Haiti that was guided by the 
IMB model. The population was a small group of HIV positive individuals, who were 
also alcohol users. CBSM-A focused on their cognitive/self-management and coping 
barriers that impeded dependable outcomes. The purposes of the treatment program were 
to a) provide participants with information on HIV disease and its treatment, including 
anti-retroviral medications, negative effects of substance abuse, and high-risk sexual 
behavior on the immune system and health in HIV; and b) teach anxiety reduction skills, 
such as progressive muscle relaxation, relaxing imagery, and autogenic exercise (Dévieux 
et al., 2009). The final phase of CBSM-A integrates cognitive appraisals of stressors 
within the context of interpersonal stressors. The primary goals were to improve contact 
with their social network and decrease conflict by enhancing communication skills 
through anger management and assertion skills. Figure 5 illustrates the training sessions 
implemented in the parent study. 
 
Figure 5. Subject and Outlines of Cognitive Behavioral Stress Management (CBSM-
A) Intervention Session 
 
Session Outline 
1 – 3  
• Focus on risk reduction strategies and information (HIV transmission, 
ART medications and adherence issues, impact of alcohol on sexual 
risk and maintaining physical health)  
• Stress management techniques focus on cognitive restructuring to 
introduce the notion that cognitions precede behavioral, affective (e.g. 
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depressed mood), social (e.g. withdrawal), physical (e.g. muscle 
tension) and physiological (e.g. hormonal) responses to stressors.  
• Special emphasis on how alcohol may influence this process in life or 
interaction with a sexual partner 
• As participants learn about identifying automatic thoughts (including 
cognitive distortions), they also learn how to use rational thought 
replacement to substitute cognitive reappraisals and thereby reduce 
distress responses. 
• Behavioral role-play. Participants receive supportive group feedback 
as they rehearse their newly acquired skills.  
4 – 5  
Focus of the stress management segment of each session shifts to coping 
skills training 
6 
Focus of the stress management segment of each session shifts to social 
support network building and help-seeking/communication 
7 
Focus of the stress management segment of each session shifts to anger 
management 
8 
Focus of the stress management segment of each session shifts to refusal 
skills and assertiveness training  
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ART Adherence 
  Treatment Adherence. Recent studies have found varying adherence rates 
among individuals, reporting that between 18% - 73% of participants are non-adherent 
(Bangsberg, Moss, & Deeks, 2004; Catz et al., 2000; Tesoriero, et al., 2003; Purcell et al., 
2004; Castro, 2005; Wood et al., 2009). Study findings further indicate that even lower 
adherence rates can be found in PLWH coping with substance abuse and/or 
environmental and psychosocial constraints (Wood et al., 2009; Malow et al., 2010; 
Moatti, 2002; Safren et al., 2001).  
Research has identified multiple barriers to ART adherence and response, 
including poor social support (Dévieux et al., 2009; Malow et al., 2009; Bryant, 2006), 
alcohol abuse (Samet et al., 2004; Baum et al., 2010; Malow et al., 2013; Nachega et al., 
2005), negative beliefs about medicine (DiMatteo et al., 2000; Starace et al., 2002), 
depression and anxiety (Dévieux et al., 2009; Malow et al., 2013; Weaver et al., 2005; 
Krain & Fitzgerald, 2005; Ghose et al., 2013) and stigma (Castro & Famer, 2005; 
Dévieux et al., 2004; Vyavaharkar et al., 2007). 
Adherence in the Caribbean. In recent years, the increase in access to ART 
among PLWH in the Caribbean has had a significant positive impact on life expectancy 
(UNAIDS Global Report, 2013), reducing morbidity and reducing AIDS incidence 
(UNAIDS Global Report, 2013; Allen, Simon, Edwards & Simeon, 2011). However, 
concerns related to ART adherence still remain (Williams et al., 2007; Adomakoh et al., 
2004; Armstrong, Thompson, & Persaud, 2004; Mukherjee et al., 2006).  
In two different studies (Beng et al., 2011; Rivero-Mendez, Dawson-Rose, & 
Solis-Baez, 2010), in Haiti and Cuba, it was determined that some of the factors linked to 
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high adherence to ART were associated with communication with support staff 
(community health-workers, specialist physician) and self-efficacy. A study conducted in 
three Caribbean countries (Antigua and Barbuda, Grenada, and Trinidad and Tobago) 
assessed 274 individuals who were taking ART, in order to identify factors affecting 
adherence (UNAIDS, 2004). It was determined that improvements in ART adherence in 
the Caribbean may be achieved by improving counseling, reducing side effects of 
medications, and most importantly, focusing attention on alcohol users (UNAIDS, 2004).  
Adherence in women. Research focusing on gender differences in treatment 
adherence highlighted the following among HIV-positive women. In Columbia, women 
prioritized the needs of their HIV-positive children over their own adherence needs, and 
some women sold their ART to survive financially (Harris et al., 2011). In Botswana, 
nondisclosure of positive HIV status contributed to reduced adherence among women 
(Bing et al., 2001). In Sub-Saharan Africa and North America, restrictive diets and side 
effects were some of the reasons women abstained from adhering to treatment plans 
(Lucas et al., 2002).  
ART adherence among Caribbean women. There is limited research on 
adherence among women in the Caribbean. Most studies in the Caribbean focused on 
ART adherence among both men and women (Williams et al., 2007; Beng et al., 2011; 
Rivero-Mendez et al., 2010; Harris et al., 2011; Koenig et al., 2012). A study conducted 
in Puerto Rico which focused on providers’ perception of barriers to adherence in women 
with HIV/AIDS, concluded that factors that influence non-adherence behaviors were: 
gender related demands, fear of disclosure, and complexity of the treatment (Conigliaro 
et al., 2003). 
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Alcohol Abuse  
 Alcohol and adherence. Alcohol influences actions and behaviors that increase 
the risks for both acquiring and transmitting HIV and other sexually transmitted 
infections (STI) (Samet et al., 2004). Studies have found a correlation between both the 
degree of alcohol intoxication and history of alcohol abuse and higher risk-taking 
behaviors (Bryant, 2006; Samet et al., 2004). Studies focused on a sample of PLWH 
found that over half had reported alcohol abuse in the previous month (Talam et al., 
2008; Lucas et al., 2002). Other research has reported similar outcomes, finding an 
association between alcohol abuse and poor adherence to health care recommendations, 
especially with respect to adherence to medication (Samet et al. 2004; Nachega et al., 
2005; Lucas et al., 2002; Conigliaro et al., 2003; Justice et al., 2004). Research also 
shows that the severity of alcohol use is correlated with levels of non-adherence (Lucas et 
al., 2002; Conigliaro et al., 2003; Justice et al, 2004). Some negative effects of alcohol 
use on ART adherence among PLWH include associations with poor social support and 
mistrust of the medical establishment (Chesney, 2000), and unstable lifestyles that 
significantly affect the ability to adhere to ART (Shere, 1998; Lucas, Chaisson & Moore, 
1999; Cook et al., 2001).  
Although intervention programs targeting cognitions and adherence have played a 
significant role in improving adherence of ART among PLWH, some studies have shown 
that these interventions may not be sufficient to address other behavioral factors, such as 
alcohol use (Samet, et al., 2004). Studies also found that better adherence had a strong 
correlation with current abstinence from alcohol compared to those with moderate and at-
risk level of alcohol use (Golin et al., 2001; Miguez et al., 2003). Alcohol consumption 
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has also been related to HIV disease progression, such as higher level of HIV viral load 
and lower CD4 counts (Golin et al., 2001; Miguez et al., 2003).  
Alcohol abuse in the Caribbean. In the Caribbean, significant differences have 
been reported in alcohol abuse from island to island. This difference occurs in part 
because alcohol dependence rates are linked to environmental factors, such as ethnic 
differences in drinking culture (Hasin & Grant, 2002; Beaubrun, 1975). In Caribbean 
countries like Haiti, habitants are known to consume more spirit drinks (hard liquors) 
than beer and wine (Global Status Report on Alcohol and Health- Haiti, 2014). The 2014 
Global Status report on Alcohol and Health states that in Haiti, the prevalence of heavy 
episodic drinking was higher amongst males than females. Studies have found alcohol 
dependence to also be associated with anxiety and other psychiatric disorders (Hasin & 
Grant, 2002; Beaubrun, 1975; Hasin & Nunes, 1997; Shafe et al., 2009).  
Substance dependence, such as alcohol, contributes significantly to social 
problems, for instance domestic violence, that are common in many Caribbean countries 
(Gage & Suzuki, 2006; Converse et al., 2014). In a national survey conducted in Haiti, 
16% of the women who either were married or in a common law relationship, reported 
experiencing sexual violence (Gage & Suzuki, 2006). Women in the study also claimed 
that alcohol use by male partners was a risk factor for partner sexual abuse. There are 
limited studies in Haiti that focus on the impact of alcohol abuse and adherence. The 
results of this study will add to the body of knowledge necessary to continue to improve 
HIV care and management in poor resource settings. 
Gender differences in alcohol abuse. Compared to women, men are more likely 
to consume higher amounts of alcohol. This finding is more globalized and affects all 
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areas of the world differently; it is driven by a country’s region and culture (Almeida-
Filho et al., 2004; McKee et al., 2000; Siery et al., 2002). In recent decades, there has 
been increased concern about similar drinking behavior extending to both genders since 
some society’s gender differences have minimized. It is more acceptable for women to 
drink alcoholic beverages in some cultures now then it was previously. Research has 
concluded that this is due to the fact that there are increased opportunities for women to 
perform traditional male roles, especially in the workforce, which often encourages 
women to incorporate drinking into their daily lives (Bermark, 2004; Bloomfield et al., 
2001). 
Alcohol abuse among Caribbean females. The continued prevalence and 
increase in alcohol consumption has become a public health issues especially in the Latin 
America and Caribbean (LAC) region (Pyne, Claeson, & Correia, 2002). The proportion 
of all deaths worldwide that can be attributed to alcohol use is 1.5%, compared to 4.5% 
for the LAC nations (Pyne et al., 2002; Montane Jaime et al., 2014). Studies have shown 
that women drink less, and are more likely to abstain from alcohol than are men in LAC 
nations (Bloomfield et al., 2001; Pyne et al., 2002). There are very limited studies in the 
Caribbean that focus on the impact of alcohol abuse and women. Most of the studies 
focused on the role of alcohol and domestic violence.  
 
Psychological Factors  
Social support and adherence among females. Prevalence and incidence of 
HIV/AIDS is increasing among women (WHO, 2014; Sambisa, Curtis, & Mishra, 2010), 
and a supportive social support environment is critical for those with HIV/AIDS. 
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Numerous studies have indicated that adherence to ART may be related to social support 
(Sowell & Phillips, 2010; Katz et al., 2013; Ansari & Gaestel, 2010). The following 
studies outlined below highlight some of the common findings in social support and ART 
adherence among women. 
Studies focusing on women investigated their perceptions of social support and 
how it affected their medication adherence. Findings from the studies concluded that 
facilitators of adherence to HIV care also included the need for supportive family 
members, (Pyne et al., 2002; Sambisa et al., 2010) desiring emotional support, and 
instrumental support (Pyne et al., 2002). This is noteworthy, given that researchers have 
demonstrated that severe life stress is a predictor of early disease progression and poor 
health outcomes (Dilorio et al., 2009; Tyler-Viola et al., 2014; Sowell & Phillips, 2010; 
Katz et al., 2013; Ansari & Gaestel, 2010; Li et al., 2011; Pyne et al., 2002; Sambisa, 
Curtis, & Mishra, 2010). 
 Social support and adherence in the Caribbean. There are limited studies 
focusing specifically on Caribbean women and social support. Numerous studies 
conducted in LAC nations have presented similar findings regarding the importance of 
perceived social support and adherence to regimen and access to care (Bing et al., 2001; 
Bingham et al., 2003). Similar findings were also made in studies conducted in the 
Dominican Republic, which aimed at determining risk factors to medication non-
adherence in HIV infected individuals; researchers concluded that perceptions of less 
social support were related to low adherence to ART (Bing et al., 2001).  
Belief about medicine and adherence. Similar to perceived social support and 
self-efficacy, a high level of belief about the effectiveness of medicine also has a 
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significant correlation with adherence to treatment (Dilorio et al., 2009; Tyler-Viola et 
al., 2014; Sowell & Phillips, 2010). Studies aimed at identifying the determinants to 
adherence to ART among HIV patients found that predictors of high adherence were: 
high perception of self-efficacy (Dilorio et al., 2009; Tyler-Viola et al., 2014; Sowell & 
Phillips, 2010), positive attitude towards taking medication (Dilorio et al., 2009; Horne & 
Weinman, 1999; Horne, Weinman, & Hankins, 1999), not living alone (Ross et al., 1992; 
McKenzie, 1993) and being a male (Ncama et al., 2008). Further analysis demonstrated 
that high physician satisfaction, high-perceived social support, and experiencing no side 
effects were some of the factors related to positive attitude about taking medication. Also, 
a high level of self-efficacy was associated with positive perception of social support, a 
high level of physician satisfaction, and not living alone (Horne & Weinman, 1999; 
Horne et al., 1999; McInerney et al., 2008).  
 Belief about medicine in Haiti. A study that examined the association of 
depression, substance abuse, and other contextual predictors among HIV-positive 
Haitians, found that along with depression, negative attitudes about ART directly 
predicted poor adherence (Malow et al., 2013). Similar to other research, this study also 
found that belief about medication predicted participants’ adherence better than 
depression (Malow et al., 2013; Nachega et al., 2005). Additionally, greater partner 
conflict, maladaptive coping, such as avoidance and denial, and alcohol problems 
predicted more depression; furthermore, maladaptive coping predicted a negative attitude 
about ART (Malow et al., 2013; DiMatteo et al., 2000; Starace et al., 2002; Weaver et al., 
2005). Other studies also presented similar findings, suggesting that incorporating 
communication about the significance of ART adherence (Cook et al., 2005; Meena et 
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al., 2014) and enhancing relations between patients and care providers (Root & 
Whiteside, 2013) are essential for positive health outcomes. 
Gender differences and belief about medicine. There are few studies that focus 
on HIV-positive females and adherence to ART as it relates to beliefs about medicine. 
Studies that focused on adherence to medication in female populations concluded that 
side effects of the medication were the main reason for non-adherence (Cocohoba et al., 
2013; Kibicho & Owczarzak, 2011; Bask, van Mill & Sathyanarayana, 2009). The 
importance of the role of health professionals in educating on the purpose of the 
treatment, which may lead to increased confidence in medication (Silveira et al., 2014; 
Nachega et al., 2012; Garvie et al., 2011), and developing symptom-management 
interventions for individuals were also significant factors related to adherence (Garvie et 
al., 2011; Campos et al., 2008; Sumari-deBoer et al., 2012). 
Depression and anxiety and ART adherence. In numerous studies, depression 
was a major predictor of lower adherence (Dévieux et al., 2009; DiMatteo et al., 2000; 
Weaver et al., 2005; Krain & Fitzgerald, 2005; Ghose et al., 2013). These conclusions 
provide evidence that suggests that including treatment for depression and anxiety may 
have a positive outcome on adherence (Kong  et al., 2012; Monroe et al., 2013; Maharaj 
et al., 2013; Garcia Bayer & Carcamo, 2014). Findings suggest that using a brief 
screening procedure to assess anxiety and depression symptoms before initiating ART 
helps to identify individuals for interventions, and therefore, improve adherence and 
quality of life (Monroe et al., 2013; Maharaj et al, 2013; Garcia Bayer & Carcamo, 2014).  
Depression and anxiety in Haiti. Caribbean women have the highest HIV-
infection rates among women in the Americas (UNAIDS Global report, 2013; Castro & 
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Farmer, 2005; Deacon, 2006). In a study conducted in Haiti, it was found that depression 
and negative attitudes about ART directly predicted poorer adherence (Malow et al., 
2010). Findings demonstrate that depression and anxiety are common among the target 
population and rank among the strongest predictors of non-adherence to ART. Other 
studies have presented similar findings in Haiti and other Caribbean countries (Malow et 
al., 2013; Monroe et al., 2013; Maharaj et al., 2013; Garcia, Bayer, & Carcamo, 2014; 
Baird et al., 2012)  
 
Social Factors  
In addition to psychological factors, this proposed dissertation also examined the 
role of some social factors, such as availability of perceived stigma, marital status, and 
education, on adherence to medication.   
Perceived Stigma.  The first seminal work on the role of stigma on health was 
published in the 1880s by Erving Goffman. Goffman, a sociologist, developed the 
benchmark social theory of the association between stigma and disease (Sumari-deBoer 
et al., 2012). Stigma is defined as an attitude and behavior toward a social group of a set 
of people based on some physical, behavioral, or social trait perceived as being different 
from the group norms (Sumari-deBoer et al., 2012). There are multiple studies focused on 
AIDS-related stigma as a barrier to counseling and testing, as well as its role in 
negatively affecting HIV care (Gordillo et al, 1999; Neame & Hammond, 2005; Riekert 
& Drotar, 2002; Reynolds et al., 2004; Sumari-deBoer et al., 2012; Herek, 1999; Deacon, 
2006; Brown, Trujillo, & Macintyre, 2001). Stigma has several challenges, but the 
mechanisms by which it relates to AIDS still needs to be studied further. Due to this 
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complexity, most researchers advocate for a blend of anti-stigma interventions for 
HIV/AIDS (Brown et al., 2001), such as community educational communication 
campaigns, and suggest that education about stigma is also included in counseling, 
coping skills, and contact with PLWH (Sankar et al., 2002; Lopez et al., 2007).  
Perceived stigma and adherence. Fear, discrimination, and shame are all 
associated with stigma. This can cause an individual with HIV/AIDS to have negative 
psychological outcomes (Gordillo et al., 1999), avoid care and services (Cats et al., 2000; 
Sumari-deBoer et al., 2012; Herek, 1999; Deacon, 2006; Brown et al., 2001), impede 
adherence to ART (Sowell & Phillips, 2010; Katz et al., 2013; Ansari & Gaestel, 2010; 
Li et al., 2011) and subsequently continue the spread of the disease (Gordillo et al., 1999; 
Sumari-deBoer et al., 2012).   
Perceived stigma and adherence in females. Studies have found that stigma 
may be problematic especially among females (Fawzi et al., 2010; DeSantis, Thomas, & 
Sinnett, 1999; Arrivillaga et al., 2011; Do et al., 2010; Mills et al., 2006; Lillard & Panis, 
1996; Smith & Waitzman, 1994; Bourne, 2009; Waldron, Hughes, & Brooks, 1996). 
Researchers found that women reported selective adherence to ART in order to protect 
themselves and their children (Smith & Waitzman, 1994; Bourne, 2009; Waldron et al., 
1996; Mitiku, Abdosh, & Tekelmariam, 2014) and noted that taking medication reminded 
them of their diseases (Mitiku et al., 2014; Peltzer et al., 2010). Researchers have found 
that social forces, such as racism, sexism and poverty, not only aggravate perceived 
stigma when all are present, but especially more where political violence and social 
inequalities also exist (Sumari-deBoer et al., 2012). Additionally, gender inequality also 
plays a significant role in AIDS-related stigma; the disclosure of HIV infection can lead 
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to higher risk of domestic violence than in environments where women enjoy gender 
equality (Lucas, 2005; Kobin & Sheth, 2011; Bangsberg et al., 2001; Sumari et al., 2012), 
and lead to declines in HIV testing (Paasche-Orlow et al., 2006). 
Relationship status and educational attainment. There are multiple studies that 
indicate that literacy, especially low health literacy (Franke, Murray, & Shin, 2011; 
Weiss et al., 1994), and marital status (Parsons, Rosof, & Mustanski, 2008) has been 
associated with low adherence to ART. A study in Ethiopia, examining ART adherence 
among 238 HIV-positive individuals, found that higher adherence rate was observed 
among participants with high school and above education and single study participants, 
compared to married study participants. However, these factors did not significantly 
affect the adherence rate of the participants (DiMatteo, 2004; Paasche-Orlow et al., 
2006). Similar findings and results were also reported by other studies (DiMatteo, 2004; 
Paasche-Orlow et al., 2006; Mitiku, Abdosh, & Teklemariam, 2013; Peltzer et al., 2010). 
Since the formal education rates in Haiti are reported to be among the lowest in the 
Western Hemisphere (UNICEF, 2009; WHO, 2013), this study evaluated whether similar 
results were obtained.  
 
Summary of the literature 
This study examined the relationship between adherence to ART and a number of 
variables, including depression and anxiety, beliefs about medicine, social support, 
perceived stigma, relationship status and educational attainment among HIV-positive 
female Haitian alcohol users. The Theory of Planned Behavior/Reasoned Action and the 
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Information Motivation Behavioral (IMB) Skills model were utilized to help 
contextualize the research findings.  
The literature shows that inadequate ART adherence is associated with increased 
progression to AIDS, mortality, emergence of viral resistance, and higher risk of 
HIV/AIDS transmission. There is limited research on adherence among women in the 
Caribbean, however studies suggest that increased access to ART has had a significant 
impact on life expectancy. Improvements in ART adherence in the Caribbean may be 
achieved by improving counseling, reducing side effects of medications, and most 
importantly, focusing attention on alcohol users.  
The research has shown that social support is a critical factor in improving 
adherence. This support may include emotional and instrumental support as well as 
having supportive family members. An individual’s beliefs about medicine are also an 
important contributor to whether they will adhere to their medication regimen or not. 
Some research has even shown that beliefs may predict adherence better than their levels 
of depression.  
In numerous studies, depression was a major predictor of lower adherence and 
several found that including treatment for depression and anxiety may have a positive 
outcome on adherence. Studies conducted in Caribbean countries demonstrate that 
depression and anxiety are common and rank among the strongest predictors of non-
adherence to ART.  
 The impact of social factors on adherence was also investigated. For many 
individals living with HIV, the fear associated with being stigmatized may cause them to 
avoid care and services. Racism, sexism and poverty have also been found to aggravate 
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perceived stigma. Research has shown that a blend of anti-stigma community 
interventions, counseling, and coping skills may be effective in reducing stigma. In terms 
of other social factors, higher adherence rates have been observed among participants 
with high school and higher education and among single study participants, compared to 
married study participants, however these factors were not significant.   
These studies provide context for this current study and indicate the factors that 
may be related to adherence in the literature. The next chapter demonstrates how the 
measures, scales, and instruments used in this study fit into the model chosen for 
analysis. 
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CHAPTER III 
METHODS 
 This dissertation research analyzed pre- and post-intervention measures from the 
parent study which utilized a randomized clinical trial and is described in the following 
paragraphs. 
Parent Study. In 2008, Florida International University’s (FIU) AIDS Prevention 
Program (APP), located in Miami, Florida, was awarded a grant by the National Institute 
of Alcohol Abuse and Alcoholism (NIAAA), entitled "Intervening with Haitian HIV+ 
Alcohol Users: An Environmental Psychosocial Framework.” This five-year study was 
an adaptation and randomized trial of a Cognitive-Behavioral Stress Management 
(CBSM) intervention for enhancing safer sex practices, adherence to ART, and reducing 
alcohol or other drug (AOD) use in a predominantly poor urban population in Haiti. The 
study was conducted at the site of clinical research partner, the Groupe Haitien d’ Etude 
du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) in Port-au-Prince, 
Haiti. A key focus of the study was to observe how HIV intervention outcomes could be 
influenced by environmental and psychological factors. 
Parent Study: Design. Data were analyzed from this NIH-funded study, which 
was conducted by Dr. Jessy G. Dévieux and the late Dr. Robert Malow. Participants who 
met the study criteria and agreed to participate in the study completed the intake 
assessment; participants were recruited in cohorts of sixteen. At the end of the 
interventions, participants in both groups completed the post assessment, and then 3-, 6- 
and 12-month face-to-face follow up visits. Once a single-sex cohort of 16 males or 16 
females had consented, participants completed baseline assessments and were 
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randomized in equal numbers to either the experimental group (CBSM-A) or the wait-list 
control group. 
Participants in a given cohort followed the same assessment schedule in both 
conditions; they were interviewed at baseline, then within a week post-intervention, and 
at 3-, 6-, and 12 month post intervention. While the group assigned to the experimental 
condition participated in the small group CBSM intervention within a week of 
completing their baseline assessment, those randomized to the wait-list control group 
received the intervention after the 6-month assessment point. The primary proposed 
outcome for the parent study was a reduction in sexual risk behaviors, and the secondary 
proposed outcomes were reductions in AOD use, improved adherence to ART, utilization 
of HIV primary care services, and enhanced psychosocial health. 
Parent Study: Recruitment. The recruitment sites were the clinics at the 
GHESKIO centers in Port-au-Prince, Haiti. GHESKIO was the first institution in the 
world dedicated exclusively to respond to HIV/AIDS. Established in 1982, GHESKIO 
has and continues to provide free medical care to all their HIV-positive patients. 
GHESKIO has the most experienced medical team in Haiti for the treatment and 
diagnosis of diarrheal diseases, tuberculosis, and STIs, including HIV infections 
(GHESKIO, 2013). GHESKIO and its network of clinics provide ART to approximately 
half of the Haitians who receive ART. Currently, the center receives about 200,000 
patient visits annually; the population served by the clinic is comprised of Haiti’s extreme 
poor and includes those at highest risk for communicable diseases (GHESKIO, 2013).  
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Parent Study: Inclusion/Exclusion Criteria. Participants were HIV-positive alcohol 
users (both men and women) living in Port-au-Prince, Haiti. Inclusion and exclusion 
criteria included:  
• > 18, but < 60 years of age, 
• Fluency in spoken Haitian Creole which is required to complete assessments and 
to participate in the intervention groups, 
• Documentation of HIV seropositivity,  
• At least one episode of unprotected anal or vaginal sex in the past 90 days, 
• Recent alcohol consumption indicated by a score >7 on the AUDIT, which is a 
10-item survey measuring alcohol consumption, dependence symptoms, and 
personal and social harm reflective of drinking over the past 30 days, 
• Currently not cognitively impaired, since cognitive impairment may compromise 
the ability to comprehend and participate in the assessment and intervention,  
• Currently not showing symptoms of a major psychiatric disorder, including 
psychosis or a high risk for suicide, since these conditions might compromise the 
ability to comprehend and participate in the assessment and intervention.   
Parent Study: Method and procedures. All potential eligible participants at the 
GHESKIO Centers were informed of the study by the research staff. Those potential 
participants who were interested were offered a pre-screening interview. At meeting 
appointments, recruiters explained all aspects of the consent forms and the study 
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procedures, including assessment and group sessions, confidentiality, and the incentive 
structure. Special attention was given to ensure that participants understood that their 
involvement was strictly voluntary. After entering the GHESKIO center and meeting 
inclusion criteria, the contents of the 8 (eight) group sessions, the assessment instruments, 
and the sequence of events, which typical study participants experienced, are listed 
below:  
1. First intake assessment  
2. Second intake assessment  
3. Randomization to one of the two conditions, CBSM-A or wait-list control 
4. CBSM-A and wait-list control Post assessment 
5. 3 month face-to-face follow-up 
6. 6 month face-to-face follow up  
7. Intervention:  Wait list control group 
8. 12 month face-to-face follow up  
Parent Study: Participant Incentives. At each assessment visit, participants 
received reimbursement for transportation in Haitian currency (100 Gourdes = U.S. 
$2.50), and were offered a phone card, and light refreshments equivalent to a total of U.S. 
$5 per visit for the pre-and post-assessment visits. At the 3-month, 6-month and 12-
month post-intervention follow up visits, participants received phone cards valued at 200, 
250, and 300 Gourdes (U.S. $5, U.S. $6.25 and U.S. $7.5) respectively, in addition to 
receiving reimbursement for transportation and light refreshments. Incentives for subject 
participation were provided immediately upon completion of each follow-up assessment. 
At each intervention group session, participants were also reimbursed for transportation 
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and received light refreshments. They also received one gift certificate to purchase food 
at a local store only after attending all the 8 intervention sessions. 
Parent Study: Intervention. Cognitive Behavioral Stress Management – 
Adapted (CBSM-A) occurred in a structured weekly group format, and the sessions took 
place twice a week in 2-hour sessions for a total contact time of four hours per week for 4 
consecutive weeks. In tailoring the intervention for this particular population, researchers 
were acutely aware of the importance of maximizing the cultural appropriateness of 
treatment strategies to all participants. Some considerations included participants’ 
familial orientation and the importance of trust and respect in interpersonal relationships, 
as well as specific Haitian attitudes toward sexuality and drug use. The format of this 
intervention was structured to: a) use group members and group leaders as coping role 
models (positive social comparisons and use of social support for informational 
purposes), b) encourage emotional expression and provide the opportunity to seek 
emotional and instrumental social support, c) replace feelings of powerlessness with a 
sense of mastery and altruism (self-efficacy changes), and d) discourage avoidance and 
encourage acceptance, reframing, planning, and active coping as strategies for dealing 
with HIV symptoms and their management.   
Wait-list control group condition. In the parent study, the randomized design 
compared participants assigned immediately to the CBSM-A to those assigned to the 
wait-list control group who received the 8-session group intervention after their 6-month 
follow up assessment visit. Participants in the wait-list control were only contacted at 
their monthly medical clinic visit to ensure their well-being and continued interest in the 
study.   
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Secondary Analysis of Data Collected in Parent Study  
Current Study 
The parent study was used as a model in the design of this dissertation’s study 
with the exception of a few changes, noted below in the design and participants sections. 
Current Study: Design. The current study utilized the randomized controlled 
design, examining pre and post assessments for intervention effectiveness on ART 
adherence, as well as impacts of moderating variables upon the proposed outcome, but 
focusing on the female participants only.   
Current Study: Participants. In addition to the parent study’s 
inclusion/exclusion criteria, this dissertation research required the exclusion of male 
participants, as well as those who have not been prescribed antiretroviral medication 
since ART adherence is a primary outcome measure. Information regarding ART 
adherence was collected at the baseline and post-intervention. All potential eligible 
participants at the GHESKIO Centers were informed of the study by the research staff, 
and those interested were offered a pre-screening interview. During the pre-screening 
interview, the staff provided an overview of what the study involved, assured that the 
confidentiality of all data and test results and emphasized that the study was voluntary. 
Once it was clear that the participant understood and agreed to participate in the study, 
the informed consent form was signed, and the participant was provided a copy.   
Variables and Measures  
 From the battery of measurement instruments utilized throughout the course of 
the parent study, the following instruments were selected to measure variables in this 
research. 
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Outcome Measure 
• ART Adherence – adherence was determined by using the Adherence to 
Combination Therapy in AIDS Clinical Trials Group (ACTG) instrument. The 
ACTG was developed by the Adherence and Retention Sub-Committee of the ACTG 
Outcomes Committee (Reynolds et al., 2007). This ACTG instrument, which 
comprised of two self-reported questionnaires (baseline and follow-up), includes a 
measure of medication used in the week prior to assessment. The questionnaires and a 
5-item options self-report responses have been used extensively to measure adherence 
to ART, both in the US and globally (Reynolds et al., 2007). The questionnaires not 
only measure medication adherence, but also assisted in assessing the understanding 
of adherence, as well as the participants’ self-assessment of their adherence to the 
schedule and their reasons for non-adherence (Reynolds et al., 2007). For the purpose 
of the current study, participants’ responses ranged from 1= all my pills every day 
(100%), 2= most of my pills (80%), 3 = about one half of my pills (50%), 4= very 
few of my pills (20%) and 5 = none of my pills (0%). In order to conduct more 
extensive analyses with the adherence variable, the parent study team converted the 
ordinal scale into a quasi-continuous scale using the percentages noted above (for 
example, all my pills = 1.0, very few of my pills = 0.2).  
The Alcohol Use Disorders Identification Test (AUDIT)  
• Severity of Alcohol Use: The AUDIT is a 10-item survey, which measures alcohol 
consumption, dependence symptoms, and personal and social harm, reflective of 
drinking over the past 30 days (Sanders et al., 1993). Each of the questions has a set 
of responses and each has a score ranging from 0 to 4; all the response scores are 
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added to determine the final score (Maisto et al., 2000). A score of eight or more on 
the AUDIT suggests hazardous or problem-level drinking (Maisto et al., 2000; Bohn, 
Babaor, & Kranzler, 1995; Babor et al., 2001). In previous external research, the 
AUDIT demonstrated good content, criterion, and construct validity and reliability (α 
from .77 to .83) (Bohn et al., 1995). According to Barbor et al, 2001, scoring and 
interpretation of the AUDIT are illustrated in Figure 6. 
 
Figure 6. AUDIT Scores meaning and interpretations. 
  
Risk Level AUDIT Scores Description 
Zone 1  0 – 7 Low drinking risk or abstinence 
Zone 2  8 – 15 Consist of alcohol use in excess  
Zone 3 16 – 19 Harmful and hazardous drinking 
managed by counseling and 
continued monitoring  
Zone 4  20 – 40 Harmful and hazardous drinking 
managed by specialist for 
diagnostic evaluation and treatment 
 
Psychological Factors – the following instruments were used and collected data at 
baseline and post-assessment period: 
• Social Support: using the Perceived Availability of Support Scale (PAS), social 
support was determined using an 8-item scale to indicate the likelihood that an 
individual could count on others for emotional, financial, and instrumental support 
(Ethier et al., 2002). This scale was originally developed for a study of persons with 
HIV, and responses for each item range from 1 (definitely not) to 5 (definitely yes). 
Responses ranged from 0 = never to 4 = always. For the purpose of this current study, 
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only 7 items from the scale focusing on partner support were utilized to measure 
partner support. A high score in this survey instrument indicated more perceived 
support, the minimum possible score was 0 and maximum score of 28. For the 
purpose of this current study, perceives availability of support range meaning and 
interpretations were as follow 0 – 16 = low perceived support and 17 – 28 = high 
perceived support. In previous external research, Cronbach’s alpha for this measure 
was found to be excellent, which was .85 for the HIV-positive cohort (Ethier et al., 
2002; Ickovics et al., 2000). 
• Beliefs about Medicines: The Belief about Medicines Questionnaire (BMQ) 
measures participants’ personal beliefs about the necessity of their prescribed 
medication and their concerns about taking it. It also assists in assessing relations 
between beliefs and reported adherence (Castro, 2005). The BMQ includes two 
sections: (1) the BMQ-Specific (two 5-item factors) which assesses representations of 
medication prescribed for personal use and (2) the BMQ-General (two 4-item factors) 
which assesses beliefs about medicines in general. In the parent study, a revised 
version of the BMQ (14-items) was utilized. The questionnaire was broken down into 
four subscales on a 5-point scale (1 = strongly agree; 2 = agree; 3 = uncertain; 4 = 
disagree and 5 = strongly disagree). The 4 subscales in total, 2 about medications in 
general – Distrust (8-items) and Benefit (5 items) which assessed perceptions about 
medicine in general; and 2 about highly active antiretroviral therapy (ART) – 
Necessity (8 items) and Concerns (11 items) assessed perceptions about ART 
(Gonzalez et al., 2007). The revised version has the same subscales but fewer items 
were utilized in the current study. The subscales were scored by multiplying number 
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of items in each subscale by number of scale responses and composite scores of each 
subscale were interpreted as follows and illustrates on Figure 7.  
o Distrust Subscale - scores near 20 (the maximum score) indicated that the 
person trusts medications a lot; the higher the score, higher the trust. 
o Benefits Subscale -  scores near 10 (the maximum score) meant that the 
person does not see any benefits to taking medications; the Lower the score, 
greater the benefit 
o Necessity of ART subscale -: scores near 20 (the maximum score) meant that 
the person does not see the necessity of taking medications; lower the score, 
greater the necessity. 
o Concerns about ART subscale - scores near 20 (the maximum score) indicated 
that the person has no concerns about taking medications; higher the score, 
lower the concern. 
Figure 7. Beliefs about medicines scores and interpretations 
Beliefs about Medicines Subscales  
 Distrust  Benefit  ART – 
Necessity 
ART – 
Concerns  
Minimum 
score  
4 2 4 4 
maximum 
score  
20 10 20 20 
Low score 
range 
4 – 12 
does not trust 
medicine in 
general 
2 – 6  
 greater benefit 
about medicine in 
general  
4 – 12  
greater the 
necessity of 
medications 
4 – 12  
high concern 
about 
medications 
High score 
range 
13 – 20 
does trust the 
medicine in 
general 
7 – 10  
does not see 
benefit about 
medicine in 
general 
13 – 20  
does not see 
the necessity 
of 
medications  
13 – 20  
 low concern 
about 
medications 
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Studies found that adherence was associated with general attitudes to medicines; people 
who believed that medicines were harmful were less likely to take medicines as 
prescribed (Ickovics et al., 2000). In a previous research, the Cronbach's alpha for this 
instrument was found to be satisfactory and ranged from 0.69 - 0.76 (Berger, Ferrans, & 
Lashley, 2001).  
• The Center for Epidemiological Studies-Depression (CES-D), published in 1977, is 
a 15-item measure that asks how often an individual has experienced symptoms 
associated with depression, such as restless sleep, poor appetite, and feeling lonely, 
over the past week. Response options range from 0 to 3 for each item (0 = rarely or 
none of the time, 1 = some or little of the time, 2 = moderately or much of the time, 3 
= most or almost all the time). Scores range from 0 to 60, with high scores indicating 
greater depressive symptoms (Mardby, Akerlind, & Jorgensen, 2007; Lewinsohn et 
al., 2007). The CES-D also provides cutoff scores (e.g., 16 or greater) that aid in 
identifying individuals at risk for clinical depression, with good sensitivity and 
specificity and high internal consistency (Radloff, 1977). CES-D, scores of 16 – 26 
are considered indicative of mild depression and scores of 27 or more indicative of 
major depression (Zich, Attkison, & Greenfield, 1990; Ensel, 1986). Previous studies 
found the cut-off scores of 27 more useful for screening medical patients for 
depression than the standard cut-off of 16 (Ensel, 1986; Zich et al., 1990; Roth et al., 
2008). In a previous study, the internal consistency reliability was good for the 
overall CES-D scale (α = 0.88) and for its four factors (α = 0.67 - 0.88) (Roth, 
Ackerman, Okonkwo, & Burgio, 2008). 
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• The State Trait Anxiety Inventory (STAI) a 20-item questionnaire measures 
anxiety in adults (Thombs et al., 2008). The STAI measures two types of anxiety – 
temporary condition of “state of anxiety” (STAIS-Anxiety) and general and long-
standing “trait anxiety” (STAIT-Anxiety). Each item is rated on a four-point scale 
with higher scores positively correlated with higher levels of anxiety (Spielberger et 
al., 1983). Responses range from 1 = not at all, 2 = somewhat, 3 = moderately and 4 = 
very much. Range of scores is from 20 – 80; with higher scores indicating higher 
anxiety in the present state. For purpose of the current study, STAI scores were 
analyzed as 20 – 40 = low level of anxiety and 41 – 80 = higher level of anxiety. The 
essential qualities evaluated by the STAIS-Anxiety scale are feelings of 
apprehension, tension, nervousness, and worry. Scores on the STAIS-Anxiety scale 
increase in response to physical danger and psychological stress. Additionally, the 
STAIS-Anxiety score decreases as a result of relaxation training. On the STAIT-
Anxiety scale, consistent with the trait anxiety construct, psychoneurotic and 
depressed patients generally have high scores. A previous study found that the 
internal consistency coefficients for the scale range from .86 to .95 (Spielberger, 
1989). 
Social Factors – these instruments were used and collected data at baseline only: 
• Demographic/Background Characteristics (baseline) – adapted from the Centers for 
Disease Control and Prevention’s Intervention for HIV-Seropositive IDUs—Research 
and Evaluation (Barnes, Harp, & Jung, 2002), assesses general questions about the 
participants’ life. This instrument was used to collect variables such as relationship 
status and educational attainment. Relationship status was obtained by asking 
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about marital status; responses range from 1 = single, 2 = married, 3 = separated, 4 = 
divorced, 5 = widowed and 6 = common law. Educational attainment responses 
range from 1 = 6th grade or less to 5 = any graduate training.  
• Stigma:  The Perceived Stigma of HIV/AIDS scale (Krain & Fitzgerald, 2005; 
Ghose et al., 2013; Castro & Farmer, 2005) was used to assess the participants’ 
perceptions of HIV/AIDS related stigma. The scale is based on the conceptualization 
of stigma as having internalized as well as externalized components. The authors, 
Westbrook and Bauman (1996), hypothesize that stigma will cause greater distress 
and lower self-esteem when the stigmatizing beliefs of others and the externalized 
dimensions are internalized. The instrument has two scales. The Perceived Stigma of 
HIV/AIDS: Personal View subscale is a 24-item instrument including stigma items 
that reflect shame, guilt, blame, embarrassment, and poor self-worth because of HIV. 
Scores ranged from 24 to 96, with lower scores indicating more internalized stigma. 
The Perceived Stigma of HIV/AIDS: Public View subscale contains 24 items 
designed to obtain the participant’s perception of social stigma. Scores ranged from 
24 to 96, with lower scores indicating more perception of public stigma. For the 
purpose of this study, participants are asked to respond to each item using the Likert 
scale (strongly agree, agree, disagree and strongly disagree) and possible total 
combined scores ranging from 48 to 192, with a higher scale score indicating a lower 
degree of perceived HIV-related stigma. In a previous study, the HIV Stigma Scale 
was reliable and valid with a large, diverse sample of people with HIV; coefficient 
alphas between .90 and .93 for the instrument provided evidence of internal 
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consistency reliability (Berger, Ferrans, & Lashley, 2001). In the parent study, this 
questionnaire was only administered at baseline. 
 
Statistical analysis 
Sample Size and Data Analysis  
From the parent study, a total of 272 participants completed the intervention 
sessions, and pre- and post-test data have been collected on the variables of interest for 
this proposed dissertation; 173 (63.6%) were female of whom 94 (54.3%) were randomly 
assigned to the intervention and 79 (45.7%) to the wait-list comparison group. The 
addition of new exclusions (i.e. male participants, as well as those who have not been 
prescribed nor taking ART) in this study reduced the available sample to 116 participants. 
In order to determine power for independent samples, the latest version of G*Power, a 
tool to compute statistical power analyses, was used (Faul, Erdfelder, Lange, & Buchner, 
2007; Faul, Erdfelder, Bucher, & Lang, 2009).  
ANOVAs, point biserial correlations and t-tests were used to test hypotheses for 
determination of a significant difference between experimental and control groups 
(hypothesis #1) and to also analyze strengths of associations between ART Adherence 
and other covariates (hypothesis #2 - #5 and #8). Analysis of Variance (ANOVA) is a 
collection of statistical models used to analyze the differences between group means and 
their associated procedures, such as variation among and between groups. Developed by 
R.A. Fisher, in the ANOVA setting, the observed variance in a particular continuous 
variable is portioned to components attributable to different sources of variation. 
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ANOVA will be used to test hypotheses to analyze the significant difference between 
social factors, such as perceived stigma, relationship status, and educational attainment as 
well as the effect of alcohol abuse (hypothesis #6 - #8), on the dependent variable 
(adherence to ART) (Montgomery, 2001; Gelman, 2005). 
In the next chapter, the reported results will be summarized. 
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CHAPTER IV 
RESULTS 
Study Participants  
Of, 173 (63.6%) female patients, 94 (54.3%) were randomly assigned to the 
intervention and 79 (45.7%) to the wait-list comparison group. Of the 173 females in the 
total sample, the study sample was reduced to 116 (65 in the intervention and 51 in the 
wait-list control group) participants after exclusion of those who had not been prescribed 
ART or who reported not taking ART at the initial assessment.  
 
Characteristics of sample at Baseline  
Participants’ ages ranged from 19 to 55 years old. The average age was 36 years 
with a standard deviation of 7.96. There was no significant difference between the 
intervention group and the wait list control group on age (t (114) = -.05, p =.963). 
Participants answered questions on both the name of the antiretroviral medications they 
took, and the doses and number of pills consumed each day. Among the participants in 
the current study, approximately 25.9% (n = 30) reported taking only one pill per day, 
while the majority (n = 82, 70.7%) reported taking two pills per day. Only four 
individuals (3.4%) reported taking their ART as three pills a day.  
Participants in the study reported on their marital status. The sample was 
primarily composed of women who were involved in a relationship (n = 67; 57.76%). 
Among those in a relationship, 6.9% (n = 8) were married and 50.8% (n = 59) were in a 
common law relationship (n= 59). There was no significant difference between the 
intervention group and the wait list control group with regard to marital status (chi square 
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= .34, p = .576). Participants also reported on the highest level of education or schooling 
that they completed. The sample population was homogenous with little variability in 
educational attainment among this group of Haitian females. The vast majority (93.3%) 
had less than a high school diploma.  Women in the intervention group were over 1.6 
times as likely to have had more than six years of education than  control group members 
(p = .048). 
Table 1 
Comparison of characteristics at baseline, by assignment, in women participating in 
the randomized clinical trial of the adapted Cognitive-Behavioral Stress Management 
(CBSM-A), confined to (a) categorical variables and (b) continuous variables. 
 
1a. Categorical variables at baseline, by study assignment 
 
Characteristic CBSM-A  
N=65 
(%) 
Comparison   
N=51 
(%) 
Total 
 
P 
 
Marital status: in a 
relationship n (%) 
36 (55.4) 31 (60.8) 67 (57.8) .576 
Education: more than six 
years n (%) 
30 (46.2) 15 (30.0) 45 (38.8) .048* 
Baseline AUDIT* 
score=8 or more 
54 (87.1) 36 (76.6) 90 (82.6) .152 
Baseline ART Adherence 
     Perfect (all doses) 
     Most 
 
25 (38.5) 
11 (16.9) 
 
21(41.2) 
7 (13.7) 
 
46 (39.7) 
18 (15.5) 
 
.624 
*Significant at α < .050 
1b. Continuous variables at baseline, by study assignment 
Characteristic CBSM-A  
Mean (SD) 
Comparison   
Mean (SD) 
Total 
 
P 
 
Mean age (years) (SD) 35.97 (8.16) 36.04 (7.8) 36.0 (7.9) .963 
Mean AUDIT Score  17.4 (8.7) 14.8 (8.2) 16.3 (8.6) .110 
Baseline ART Adherence 
     Perfect (all doses) 
     Most 
 
25 (38.5) 
11 (16.9) 
 
21(41.2) 
7 (13.7) 
 
46 (39.7) 
18 (15.5) 
 
.624 
Mean ART Adherence .66 (.35) .64 (.39) .66 (.37) .740 
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Score 
Mean Stigma Score 126.9 (16.5) 129.1 (16.3) 127.9 (16.4) .510 
Mean Social Support 
Score 
15.4 (4.9) 16.5 (5.4) 15.9 (5.1) .271 
Mean Score, Depression  33.9 (9.8) 34.4 (9.5) 34.1 (9.7) .833 
Mean Score, General 
Distrust of Medication 
10.4 (2.4) 10.1 (1.9) 10.3 (2.2) .590 
Mean Score, General 
Benefit of Medication 
3.9 (.65) 3.8 (.54) 3.9 (.60) .766 
Mean Score, ART 
Concerns of Medication 
12.0 (2.8) 11.6 (2.5) 11.8 (2.7) .387 
Mean Score, ART 
Necessity of Medication 
7.6 (1.8) 7.6 (1.0) 7.6 (1.5) .8925 
Mean score of Anxiety  52.8 (8.2) 54.7 (8.4) 53.6 (8.3) .225 
 
Study Outcomes 
 There was no significant difference on alcohol use, perceived stigma and partner 
support, and beliefs about medicine between the intervention and wait-list control groups    
at post-assessment (Table 2). Adherence to ART was determined by the average percent 
of time participants self-reported taking pills as prescribed during the last seven (7) days. 
In the sample at baseline, a higher percentage of optimal adherence, meaning taking 
medication 100% of the time as prescribed was seen in 39.7% of subjects (n = 46) 
compared to only 29.3% (n = 32) at post-assessment.  The mean adherence score at post-
assessment was .52 (SD = .38). This analysis suggests an overall decline in adherence 
from baseline to post-assessment in the total sample (which includes intervention and 
wait-list control groups). At post-assessment, only 24 (36.9%) of intervention and 14 
(27.4%) of wait-list control group members reported perfect adherence or having taken 
“most” doses in the past seven days (p=.846); which was not significant.   
At baseline depression scores ranged from 1 - 56 (n = 116; M = 34.14; SD = 9.66) 
and did not differ significantly between the intervention and control groups (Table 1). At 
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post-assessment, depression symptomatology was significantly lower in in the 
intervention than in the wait-list control group (Table 2). Further analyses are discussed 
in the hypotheses section. Similarly, anxiety scores, which did not differ significantly at 
enrollment, were significantly lower in the intervention group members than wait-list 
control group members post-assessment.  
  
Table 2 
Comparison of social and psychological factors at post-assessment, by assignment to 
the adapted Cognitive Behavioral Stress Management (CBSM-A) intervention or wait-
list control condition. 
Factor CBSM-A 
 
N (%)  
Wait-List 
Control 
 
N (%) 
t/chi square P 
Proportion AUDIT* 
score=8 or more 
38 (58.5) 24 (47.1) .11 .737 
Mean Score, 
Depression Screen 
26.4 (11.3) 33.3 (9.4) -3.42 .001**
Mean Score, Anxiety  51.9 (8.4) 55.9 (8.3) -2.51 .014* 
Mean Score, General 
Distrust of 
Medication 
10.3 (2.7) 10.2 (2.6) .26 .798 
Mean Score, General 
Benefit of Medication 
3.8 (.91) 3.87 (1.1) -.08 .933 
Mean Score, ART 
Concerns of 
Medication 
12.7 (3.5) 11.6 (3.4) 1.61 .111 
Mean Score, ART 
Necessity of 
Medication 
7.3 (1.8) 7.2 (1.4) .25 .801 
Mean score, Social 
Support  
15.9 (5.2) 15.6 (5.2) .29 .776 
    *Significant at α < .050; ** Significant at α < .010 
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Statistical Analyses 
Research Question 1:  Is the Cognitive Behavioral Stress Management – Adapted 
(CBSM-A) intervention effective in improving ART adherence among HIV-positive 
Haitian female alcohol users?  
Hypothesis 1: Female participants in the CBSM-A group will show better ART 
adherence than those in the wait-list control group. 
Adherence rates significantly decreased for both groups combined (F (1, 108) = 
8.79, p = .004). On average, for both groups combined, adherence decreased from .65 
(SD =.37) at baseline to .52 (SD =.38) at post assessment. There was no significant 
difference between the intervention and control groups with regard to the magnitude of 
change between baseline and post assessment [F (1, 108) = 1.21, p = .274]. In addition, 
there was no significant difference between the intervention and control groups 
irrespective of time [F (1, 108) = 1.49, p = .226]. Hypothesis 1 was not supported.  
 
 
Table 3 
 
Descriptive statistics for ART adherence scores for CBSM-A and wait-list control 
group at baseline and post-assessment (n=110) 
 
Intervention Status    N  Mean  Standard Deviation 
Baseline  
 CBSM-A   63  .66   .35 
 Wait-list control   47  .64   .39 
Post-Assessment 
 CBSM-A   63  .57   .36 
 Wait-list control  47  .46   .40 
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The overall adherence survey also examined some of the common reasons why 
participants failed to take their ART medications. A total of 10 questions, completed both 
at baseline and post-assessment, focused on possible reasons for which participants 
missed their pills during the past seven days. Table 4 demonstrates the descriptive 
statistics at baseline (n = 116). The following were the three most common reasons 
participants failed to take ART as prescribed at baseline: 18% reported ‘I had problems 
taking pills at specified times (with meals, on empty stomach, etc.); 14.6% each reported 
‘I forgot to take the pills’ and ‘I did not want others to notice.’ At post-assessment, of the 
110 participants who responded to the ART questionnaire, only 23 participants (21%) 
responded to these questions; the remaining 79% (n = 87) responded that these statements 
were not applicable.  Analysis was not conducted for these questions for post-assessment 
due to the very low percentage of responses. Adherence did not vary significantly at 
baseline by whether patients reported that they felt worse when they took the pills, had 
too many pills, ran out, did not think they needed the pills, were away from home or were 
confused or uncertain on how to take the pills. However, reporting forgetting to take the 
pills, not wanting other to notice, being too busy or having problems taking pills at 
certain times, were correlated with significantly lower adherence (Table 4). 
Table 4 
Statistics for common reasons participants failed to take ART among CBSM-A and 
wait-list group members at baseline (n = 116) 
 I forget to 
take the 
pills 
I did not want 
others to notice
I am too 
busy 
I had problems taking 
pills at specified times 
(with meals, on empty 
stomach, etc.) 
No 99 99 111 95 
Yes 17 17 5 21 
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Correlation -.230 -.197 -.247 -.207 
Sig (2-
tailed) 
.013* .034* .008** .026* 
     *Correlation is significant at the 0.050 level (2-tailed) 
     ** Correlation is significant at the 0.010 level (2-tailed) 
Research Question 2: Are the psychological factors—social support, depression, 
anxiety, and beliefs about medicine—associated with ART adherence at baseline and 
post-assessment among HIV-positive Haitian female alcohol users in the intervention 
group? 
Research Question 3: Do psychological factors—social support, depression, anxiety, 
and beliefs about medicine— improve from baseline to post-assessment among HIV-
positive Haitian female alcohol users at the end of the intervention? 
 
Point biserial correlations were calculated to determine the relationships between 
psychological factors – social support, depression, anxiety, and beliefs about medicine – 
and ART adherence.   Table 3 demonstrates findings.  
 
Hypothesis 2a: Lack of social support will be inversely related to ART adherence among 
HIV-positive Haitian adult females. 
There was no significant relationship between social support and ART adherence 
at baseline (r = -.097, p = .440). However, at post-assessment adherence was significantly 
correlated with social support (r = -.249, p = .049). This hypothesis was partially 
supported. 
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Hypothesis 2b: Social support will improve among HIV-positive Haitian adult females at 
the end of the intervention. 
Among those in the intervention group, social support did not change from 
baseline (M = 15.36, SD = 4.94) to post-assessment (M = 15.86, SD = 5.18); t (64) = -
.93, p = .356).  This hypothesis was not supported. 
 
Hypothesis 3a: Depression and anxiety will be inversely correlated with ART adherence 
among HIV-positive Haitian adult females.   
Depression.   There were no significant relationships between depression and 
ART adherence at baseline (r = -.023, p = .856) or at post-assessment (r = .058, p = .655). 
This hypothesis was not supported. 
Anxiety. There were no significant relationships between anxiety and ART 
adherence at baseline (r = .195, p = .120) or post-assessment (r = -.175, p = .174). This 
hypothesis was not supported.  
 
Hypothesis 3b: Depression and anxiety will improve among HIV-positive Haitian adult 
females at the end of the intervention. 
Depression. A paired samples t-test was utilized to assess changes in depression 
between baseline and post assessment for those in the intervention group. On average 
depression decreased from 34.06 (SD = 9.85) to 26.37 (SD = 11.27) (t (62) = 5.54, p < 
.001). At post-assessment, patients assigned to the CBSM-A had significantly lower 
depression scores than patients assigned to the wait-list controls 
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Anxiety. A paired samples t-test was utilized to assess changes in anxiety 
between baseline and post assessment for those in the intervention group. On average 
anxiety scores did not improve from baseline 52.65 (SD = 8.25) to post-assessment 51.89 
(SD = 8.35) (t (63) = .74, p = .462).   Hypothesis 3b was partially supported.  
 
Hypothesis 3c. Patients randomized to CBSM-A will have lower depression and anxiety 
scores at post-assessment than those assigned to wait-list control group.  
Depression. At post-assessment, patients assigned to the CBSM-A had 
significantly lower depression scores than patients assigned to the wait-list controls (26.4 
[SD=11.3] versus 33.3 [SE=9.4]; p=.001).  
Anxiety. Similarly, at post-assessment, patients assigned to the CBSM-A had 
lower anxiety scores than control-group members (51.9 [SD=8.4] versus 55.9 [8.3]; 
p=.014). Hypothesis 3c was supported.  
 
Hypothesis 4a: High beliefs in the value of medicines will be positively associated with 
ART adherence among HIV-positive Haitian adult females.  
Scores in distrust (r = .111, p = .382); benefits (r = -.141, p = .263); ART 
concerns (r = -.025, p = .842) and ART necessity subscales (r = -.067, p = .597) at 
baseline were not associated with significant differences in adherence. Similarly scores at 
post-assessment, (distrust (r = .136, p = .289); benefits (r = -.054, p = .673); ART 
concerns (r = .076, p = .569) and ART necessity subscales (r = .031, p = .816) were not 
associated with significant differences in adherence. This hypothesis was not supported. 
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Hypothesis 4b: Beliefs in the value of medicines will improve among HIV-positive 
Haitian adult females at the end of the intervention. Hypothesis 4b was not supported. 
 Paired-sample t-tests were conducted to compare baseline and post-assessment 
scores:  
• BMQ scales: general distrust did not significantly change between baseline 10.35 (SD 
= 2.38) and post-assessment 10.30 (SD = 2.72) for the intervention group t (62) = 
.126, p = .900.  
• BMQ scales: general benefits did not significantly change between baseline 3.88 (SD 
= .65) and post-assessment 3.75 (SD = .91) for the intervention group t (63) = 1.07, p 
= .289.  
• BMQ scales: ART concerns did not significantly change between baseline 12.07 (SD 
= 2.74) and post-assessment 12.68 (SD = 3.52) for those in the intervention group t 
(59) = -1.38, p = .173.  
• BMQ scales: ART necessity benefits did not significantly change between baseline 
7.57 (SD = 1.72) and post-assessment 7.28 (SD = 1.82) for those in the intervention 
group t (59) = 1.25, p=.217.  
Table 5 
Comparison of behavioral and psychological factors at post-assessment, for the 
adapted Cognitive Behavioral Stress Management (CBSM-A) intervention. 
Factors Adherence 
Mean (SD) 
Prevalence 
95% CI 
t P 
Depression  .64 (.46) 
  
-.27 to .20 
 
-.31 
 
.761 Not depressed  .68 (.30) 
 
High Anxiety .67 (.34)    
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 -.34 to .22 -.42 .677 
Low anxiety  .61 (.46) 
 
High social support .63 (.39) 
  
-.12 to .24 
 
.65 
 
.518 Low social support .69 (.32) 
 
High stigma  .66 (.34) 
  
----- 
 
----- 
 
----- Low stigma ^ 
 
High BMQ Distrust .79 (.33) 
  
-.39 to .08 
 
-1.34 
 
.184 Low BMQ Distrust .64 (.35) 
 
High BMQ Benefit  ^^ 
  
----- 
 
----- 
 
----- Low BMQ Benefit  .67 (.35) 
 
High BMQ ART 
Necessity  
.63 (.47) 
  
-.38 to .45 
 
.17 
 
 
.866 Low BMQ ART 
Necessity  .67 (.35) 
High BMQ Concerns  .67 (.38)  
-.18 to .18 
 
-.03 
 
.979 Low BMQ Concerns .67 (.34)  
^ All but one subject was in the high group; ^^ All subjects were in the low group 
 
Table 6  
Point biserial correlations of psychological factors – anxiety, depression, social support 
and ART adherence at baseline and post-assessment for intervention group. 
 
Adherence to ART Anxiety Depression Social Support Base Post Base Post Base Post 
Baseline 
Pearson Correlation 
Sig. (2-tailed) 
N 
 
.195 
.120 
65 
 
.062 
.630 
63 
 
-.023 
.856 
65 
 
-.030 
.815 
62 
 
-.097 
.440 
65 
 
-.041 
.750 
64 
Post-Assessment 
Pearson Correlation 
Sig. (2-tailed) 
N 
 
-
.054 
.673 
63 
 
-.175 
.174 
62 
 
-.175 
.171 
63 
 
.058 
.655 
61 
 
-.259 
.041 
63 
 
-.249 
.049* 
63 
     *Significant at α < .050; ** Significant at α < .010 
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In summary, regarding psychological factors – social support, beliefs about 
medicines, depression and anxiety were not correlated with adherence. However, citing 
various reasons why they would not take their medication (forgetting, not wanting others 
to notice, being too busy, and having problems taking pills at specific times relative to 
meals) was significantly associated with lower adherence. 
 Social support and all scores in the BMQ subscales did not significantly change 
between baseline and post-assessment. However, depression significantly decreased from 
baseline to post-assessment in the intervention group. Anxiety did not decrease from 
baseline to post-assessment. At post-assessment, both depression and anxiety scores were 
significantly lower in patients in the CBSM-A group than in controls.   
 
 
Research Question 4: Do the social factors — perceived stigma, relationship status and 
educational attainment — affect ART adherence among HIV-positive Haitian female 
alcohol users?  
Hypothesis 5: Lack of perceived stigma will be inversely related to ART adherence 
among HIV-positive Haitian adult females.  
There was no significant relationship between stigma and ART adherence at 
baseline (r = -.021, p = .880) or stigma at baseline with ART adherence at post-
assessment (r = -.087, p = .521). This hypothesis was not supported. 
 
Hypothesis 6: Participants in a relationship will have higher adherence than those not in 
a relationship. 
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No significant difference was seen in mean adherence scores at baseline or post-
assessment by relationship status; (baseline: ‘in a relationship’ M= .64; SD = .38, ‘not in 
a relationship’ M = .70; SD = .32; t [63] = .58, p = .566; post-assessment: ‘in a 
relationship’ M= .58; SD = .37, ‘not in a relationship’  (M = .56; SD = .36; t [61] = -.24, 
p-value = .812). This hypothesis was not supported. 
 
 
Hypothesis 7: Participants with lower educational attainment will have lower ART 
adherence values. 
There was no significant difference in ART adherence for participants who 
reported having ‘less than a 6th grade education’ in this sample at baseline (M= .62; SD = 
.36) and those who reported ‘more than a 6th grade education’ (M = .71; SD = .36); t (60) 
= -1.05, p = .296 at baseline or at post-assessment (‘less than a 6th grade education’ (M= 
.60; SD = .36 ‘more than a 6th grade education’ M = .51; SD = .37; t [58] = .968, p = 
.337). This hypothesis was not supported.  
Research Question 5: Does the degree of alcohol abuse affect ART adherence among 
HIV-positive Haitian female alcohol users? 
Research Question 6: Does the degree of alcohol abuse change between baseline and 
post-assessment in response to the intervention among of HIV-positive Haitian female 
alcohol users?   
 
Hypothesis 8a: Alcohol use will decrease among HIV-positive Haitian adult females at 
the end of the intervention. 
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 For both groups combined, alcohol use significantly decreased between baseline 
and post-assessment from 18.58 (SD = 7.91) at baseline to 13.78 (SD = 6.93) at post-
assessment (1, 78) = 34.70, p < .001 There was no significant difference between the 
intervention and control groups with regard to the magnitude of change between baseline 
and post-assessment (F (1, 78) = 3.20, p = .078). In addition, there was no significant 
difference between the intervention and control groups irrespective of time F (1, 78) = 
.005, p = .943.  This hypothesis was partially supported. 
 
 
Hypothesis 8b: Greater alcohol use severity will be associated with lower ART 
adherence among HIV-positive Haitian adult females. 
There were no significant relationships between alcohol use and ART adherence 
at baseline (r = .03, p = .804) or at post-assessment (r = .007, p = .961) (Table 7). This 
hypothesis was not supported. 
 
 
Table 7 
 
Alcohol and ART adherence between baseline and post-assessment for both groups   
 
Intervention Status    N  Mean  Standard Deviation 
Baseline  
 CBSM-A   62  17.43   8.69 
 Wait-list control   47  14.79   8.24 
Post-Assessment 
 CBSM-A   50  13.34   6.40 
 Wait-list control  33  14.24   7.72 
 
In summary, results from this current study show that none of the psychological 
factors - perceived social support, beliefs about medicines, depression and anxiety were 
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correlated with adherence neither at baseline nor at the end of the intervention. 
Additionally, social support, anxiety and the BMQ subscales did not significantly change 
between baseline and post-assessment. Depression significantly decreased from baseline 
to post-assessment, only in the CBSM-A group. However, at post-assessment, women in 
the CBSM-A group had significantly lower depression and anxiety scores than controls. 
Overall, there was a decrease in ART adherence from baseline to post-assessment among 
both the CBSM-A and wait-list control group. At the end of the intervention, there was a 
23% decrease in the number of HIV-positive, female Haitian alcohol users who reported 
consuming alcohol. Furthermore social factors analyzed in this study, marital status, 
perceived stigma and education attainment, were also not correlated with adherence 
among the sample population. Several reasons for not taking medications were associated 
with reporting lower ART adherence, specifically, forgetting, not wanting others to 
notice, being too busy, and having problems taking pills at specific times relative to 
meals.   
 
The next chapter will discuss the results illustrated in Chapter IV. The following 
chapter will also address limitations of the study, practical implications and 
recommendations for future research. 
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CHAPTER V 
DISCUSSION 
The purpose of this study was to determine whether an intervention that has been 
used successfully for treatment of depression had an impact on ART adherence, as well 
as on depression and anxiety, in female Haitian alcohol-abusing ART patients. It also 
sought to examine psychological predictors, such as, depression, anxiety, beliefs about 
medicine, and social support, as they relate to adherence to ART among HIV-positive 
female Haitian alcohol users. In addition, this study examined the role of stigma on 
adherence to ART. Participants’ relationship status and education were also investigated 
in order to establish whether there was a link to ART adherence. Next, the study explored 
how the level of alcohol consumption among the participants affected their adherence to 
prescribed ART.  
 Several interesting findings emerged from this study. First, none of the 
psychological or social factors was statistically associated with ART adherence in this 
sample. Secondly, depression scores declined among the participants in the CBSM-A 
group and at post-assessment were significantly lower than in the controls, suggesting 
that the intervention was at least as effective in this group as in other populations. 
Similarly, the intervention group had significantly lower anxiety scores at post-
assessment than controls. Lastly, alcohol use decreased significantly among the 
participants in both groups at the end of the intervention. The sample reported relatively 
high scores of perceived stigma and depression, as well as low scores of perceived social 
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support during the study, but these factors were not found to have a relationship with 
ART adherence. Statistically significant findings are summarized in this chapter.  
 
Research Questions 
Hypothesis 1: Female participants in the CBSM-A group will show better ART 
adherence than those in the wait-list control group. 
 
In studies based in low-resource settings, ART adherence has ranged widely from 
as low as 54% (Weiser et al., 2003) to as high as 94% (Oyugi et al., 2004) in the sample 
under study. In the current study, there was an overall decrease in adherence. At post-
assessment, there was an overall 16.4% decrease among the participants (CBSM-A and 
wait-list control) who reported taking all and most of the pills when compared to the 
baseline. There was also an increase in the percentage of participants who reported not 
taking any of the pills during the past seven days by 9.5%, at the end of the intervention. 
The reported decrease in adherence rates at post-assessment may be related to the desire 
of the sample population to please the interviewer and report higher compliance to 
medications at baseline; it is possible that participants felt more comfortable at the end of 
the intervention and were more honest about their levels of adherence (Simoni et al, 
2007; Safren et al, 2006). The overall decrease in ART adherence was observed among 
both the CBSM-A and wait-list control group. Some of the most common reasons for 
missing the pills at baseline were aligned with perceived stigma. These findings are 
similar to other research that indicated addressing stigma (Colombini et al., 2014) 
improve adherence outcomes. Moreover, the association between lower adherence and 
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more banal issues (forgetting, busy, difficulty taking pills on an empty stomach or with 
meals) point to the possibility that the issues that drive non-adherence in this population 
have less to do with belief in the medication and more to do with the complicated lives 
that they lead, and the stigmatization of HIV.    
Similar to the current study, others research has shown no significant 
improvement in adherence among participants who participated in group education and 
counseling in poor-resource settings (Safren et al., 2013; Berger et al., 2008; Sampaio-sa 
et al., 2008), suggesting that the study populations may have benefited from diverse types 
of intervention approaches, for example, an individual component, support for group 
members or environmental support (Thompson et al., 2012; Kagee et al., 2011; Chung et 
al., 2010; Kalichman et al., 2011; Haberer et al., 2013). However, several previous 
studies conducted in Haiti showed an improvement in HIV care and ART adherence 
associated with group members support (Naslund et al., 2014; Kimmel et al., 2013; 
Severe et al., 2010). These outcomes suggest further investigations are needed to 
determine the components which may contribute the most to improved adherence. 
 
Hypothesis 2a: Lack of social support will be inversely related to ART adherence among 
HIV-positive Haitian adult females. 
Hypothesis 2b: Social support will improve among HIV-positive Haitian adult females at 
the end of the intervention. 
Hypothesis 2a was partially supported while 2b was not supported. The current 
study found that social support was related to adherence in this sample. Previous studies 
reported mixed outcomes with social support and ART adherence (Kovarth et al., 2015; 
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Langebeek et al., 2014; Kagee et al., 2010; Beng et al., 2011; Rivero-Mendez et al., 2010; 
Harris et al., 2011; Tabatabai et al., 2014; Kalichman et al., 2011; Haberer et al., 2013; 
Kagee et al., 2011). Previous studies among Caribbean women that examined social 
support generally found a relationship between social support and adherence to regimen 
(Beng et al., 2011; Rivero-Mendez et al., 2010; Harris et al., 2011). However some 
studies concluded that the presence of social support and knowledge about consequences 
of treatment interruptions were not sufficient to improve ART adherence; they suggested 
that adherence counseling sessions that provide problem-solving strategies for common 
barriers to HIV care may be required in order for adherence to improve (Tabatabai et al., 
2014; Kalichman et al., 2011; Haberer et al., 2013; Kagee et al., 2011). 
The current study analysis showed that for those in the intervention group, social 
support did not significantly change from baseline to post-assessment. Overall perceived 
social support was very low in both CBSM-A and wait-list control groups, with an 
overall average of 15.73 at both baseline and post-assessment. This finding suggests that 
HIV-positive female Haitian alcohol users in this sample were perhaps not receiving the 
level of social support that they felt that they needed and may have benefited from 
support from spouses and from others on ART (Sambas et al., 2010; Hovarth et al., 2013; 
Sasaki et al., 2012). These findings also suggest that there might be other confounding 
variables within this sample population, such as support or lack of support from health 
care staff and peer support, which were not examined in this study (Hovarth et al., 2013; 
Sasaki et al., 2012; Mugavero, Norton, & Saag, 2011). These other psychological factors 
may be associated with life circumstances that might play a role in reducing adherence.  
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Hypothesis 3a: Depression and anxiety will be inversely correlated with ART adherence 
among HIV-positive Haitian adult females.   
Hypothesis 3b: Depression and anxiety will improve among HIV-positive Haitian adult 
females at the end of the intervention. 
Hypothesis 3c: Patients randomized to CBSM-A will have lower depression and anxiety 
scores at post-assessment than those assigned to wait-list control group.  
Hypothesis 3a was not supported by the analysis while Hypothesis 3b was only 
partially supported and Hypothesis 3c was supported. The current study found that 
neither depression nor anxiety were related to adherence in this sample. In this sample, no 
relationship was found between depression and ART adherence, it is possible that the 
participants overestimated their self-reported psychopathology and data regarding level 
of depression would have been strengthened if the depression diagnosis had been derived 
from diagnostic interviews instead of self-report (Simoni et al., 2011). Furthermore, 
changes in depression over time are often associated with changes in adherence; in this 
study, the relationship between depression and ART adherence was only examined at the 
beginning and end of the intervention, therefore it is possible that a longer follow-up 
might have yielded a significant relationship (Wagner et al., 2011).    
With regard to depression, a majority of previous studies found a relationship 
between depression and ART adherence, with higher depression being associated with 
less adherence (Blashill, Gordon, & Safren, 2014; Langebeek et al., 2014; Sheth et al., 
2015; Beer & Skarbinski, 2014; Ghose et al., 2013; King et al., 2012). However, some 
have shown an association with viral suppression, but not with adherence (Beck-Sague et 
al., 2014). Moreover, depression intervention studies have yielded inconclusive findings 
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to date with regards to ART adherence outcomes (Bottonari et al., 2013; Johnson et al., 
2012; Springer, Dushai, & Azar, 2012) with some studies finding that antidepressant 
medication treatment use increased the probability of antiretroviral intake, rather than the 
intervention (Tsai et al., 2010; Tsai et al., 2013).  
The current study’s results showed no relationship between anxiety and ART 
adherence. In similar resource-poor settings other studies have reported higher anxiety 
levels being associated with lower ART adherence (Langebeek et al., 2014; Prappin, 
Wouters, & Booysen, 2012; Tesfave & Bune, 2014). In this sample, it is possible that a 
relationship was not found between anxiety and adherence because of the current high 
levels of post-traumatic stress disorder associated with the aftermath of the 2010 
earthquake; these levels, and the consequent resistance to change may explain the lack of 
significant findings (Cerdá et al., 2013; Koening et al., 2014). The high level of anxiety 
among this population may also be related to partner conflict and other psychological 
factors related with life circumstance which may need to be addressed in order to 
improve adherence (Li et al., 2014; Siemieniuk, Krentz, & Gill, 2013; Trimble, Nava, & 
McFarlane, 2013).   
For those in the intervention group, depression decreased significantly. Patients 
assigned to CBSM-A had significantly lower depression scores at post-assessment than 
controls, suggesting that the intervention, which is intended to treat depression, was 
effective in reducing depression. This improvement in mental health status is similar to 
other studies with racial/ethnic minority women infected with HIV and HPV which also 
implemented multi-component interventions focusing on coping skills and stress 
management techniques (Lopez et al., 2013; Logie James, Tharao, & Loutfy, 2014; King 
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et al., 2012; Duncan et al., 2012). Intervention group members also had significantly 
lower anxiety scores in post-assessment than controls, suggesting that the intervention 
was also effective in anxiety reduction.  
 
Hypothesis 4a: High beliefs in the value of medicines will be positively associated with 
ART adherence among HIV-positive Haitian adult females.  
Hypothesis 4b: Beliefs in the value of medicines will improve among HIV-positive 
Haitian adult females at the end of the intervention. 
Neither hypothesis 4a nor 4b were supported. The current study also found that 
beliefs in the value of medicines were not related to ART adherence in this sample. The 
majority of previous studies have found a relationship between beliefs about medicine 
and adherence, with higher levels of beliefs of medicines associated with higher 
adherence and also the opposite (Cooper et al., 2011; Malow et al., 2013; Horne et al., 
2013; Batchelder, Gonzalez, & Berg, 2014; Cooper et al., 2010; Groh et al., 2011). 
However, similar to this current study, another study also found that beliefs about 
medicines was not related to adherence (Adefolalu et al., 2015) concluding that ART 
adherence was more closely related to self-efficacy (Tyler-Viola et al., 2014; Adefolalu et 
al., 2015). When addressing psychological factors, TRA/TPB theory has tended to focus 
on attitudinal beliefs, self-efficacy, and normative and norm-related beliefs and activities. 
The current study suggest that the issues related to non-adherence in this sample are not 
so much related to intention or beliefs in the medication, but rather, practical issues 
related to the complex lives that alcohol-abusing female ART patients may lead. This is 
further complicated by the fact that they must juggle medication use while hiding it from 
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others, missing out on the adherence enhancement related to sympathetic 
“accompaniment” and support from others, suggesting that providing such support in the 
context of care may promote adherence (Behforouz, Farmer, & Mkherjee, 2004). In this 
sample, an integrative model of behavior change, whereby behavioral intentions 
combined with skills and environmental limitations affecting individual behavior, may be 
more suitable.  
After assessing each of the four subscales of the BMQ questionnaire for both the 
CBSM-A and wait-list control groups, from baseline to post-assessment, none of the 
BMQ subscales improved significantly from baseline to post-assessment, in either group. 
Similarly, for those in the intervention group, none of the BMQ subscales improved 
significantly from baseline to post-assessment. 
 
Hypothesis 5: Lack of perceived stigma will be inversely related to ART adherence 
among HIV-positive Haitian adult females.  
Statistical findings offer no significant findings for Hypothesis 5. As mentioned in 
the previous chapter, perceived stigma was only assessed at baseline. This was due to the 
fact that the main goals of the intervention were to improve participants’ social network 
and decrease conflict by enhancing communication skills through assertion techniques. 
No relationship was found between stigma and ART adherence among the combined 
CBSM-A and wait-list control groups. Previous studies have found mixed outcomes in 
the relationship between stigma and adherence to medications, however most reported a 
higher level of perceived stigma being associated with lower ART adherence 
(Onyebuchi-Iwudibia & Brown, 2014; Sumari-de Boer et al., 2012; Masquillier et al., 
 77 
 
2015; Musheke et al., 2012; Bogart et al., 2013; Musheke et al., 2013; Cardarelli et al., 
2008; Franke et al., 2011; Martinez et al., 2012; Katz et al., 2013). It is possible that a 
relationship was not found between stigma and adherence in this sample of HIV-positive 
Haitian female alcohol users because stigma was not measured at post-assessment. It is 
possible that an improved sense of peer-support and having an environment to 
confidentially discuss their experience with HIV may have increased adherence in this 
sample (Rasschaert et al., 2014; Naslund et al., 2014; Allen et al., 2011). 
Although stigma was not significantly related to adherence, one of the more 
common (and significant) reasons reported for missing pills in the past seven days was 
that the participants were afraid that someone would notice them taking their 
medications. This reason appears to be indirectly associated with stigma.  
 
Hypothesis 6: Participants in a relationship will have higher adherence than those not in 
a relationship. 
Hypothesis 6 was not supported. Over half of the population reported being in a 
relationship, however no correlation was found between adherence and being in a 
relationship vs. not being in a relationship. Findings in this sample are similar to other 
studies in which marital status was not related to adherence; the researchers concluded 
that the role of gender and household dynamics may prevent females from successfully 
adhering to ART and the fact that partners may not be aware of their HIV-positive status 
(Mitiku, Abdosh, & Teklemariam, 2013; Peltzer et al., 2010; Skovdal et al., 2011).  
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Hypothesis 7: Participants with lower educational attainment will have lower ART 
adherence values. 
Statistical findings offer no support for Hypothesis 7. Education may not have 
been a factor in this sample due the lack of variance. Over 90% of the participants had 
not obtained a high school diploma, with the majority reporting only a 6th grade level 
education and below. Similar findings were made in poor-resource settings which 
concluded that closer doctor-patient relationships and promoting self-efficacy among 
patients were predictors of successful of ART adherence, more so than education level 
(Campos et al., 2011; Arrivillaga et al., 2011). This finding does not imply that education 
is not an important predictor of adherence; further research with a sample with more 
diverse educational attainment may be necessary. No significant differences were found 
among the groups at either baseline or post-assessment. 
 
Hypothesis 8a: Alcohol use will decrease among HIV-positive Haitian adult females at 
the end of the intervention. 
Hypothesis 8b: Greater alcohol use severity will be associated with lower ART 
adherence among HIV-positive Haitian adult females. 
Hypothesis 8a was only partially supported by the analysis while Hypothesis 8b 
was not supported. The current study found that for both CBSM-A and wait-list control 
groups, alcohol use significantly decreased from baseline to post-assessment. Although 
there was a 23% decrease in the number of participants who reported consuming alcohol 
at the end of the intervention, at post-assessment, the majority (74.7%) still reported an 
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AUDIT score of 8 and above (Zone 2), which indicates hazardous or problem-level 
drinking. This represents a decrease from Zone 3 (score ranging from 16 -19) at baseline. 
The current study found that alcohol use was not related to adherence. Finding 
from previous studies report contradictory outcomes, with the majority reporting a 
relationship between alcohol and adherence, with higher alcohol use being associated 
with lower adherence (Harris et al., 2011; Teixeira et al., 2013; Raboud et al., 2011; 
Broyles et al., 2011). In this study, it is possible that a relationship was not found between 
alcohol use and adherence because data were assessed at baseline and end of the 
intervention, it is possible that more changes could have been observed at 3, 6 months 
and 12 months post-intervention. For future studies, alcohol users may require more 
focused attention and customized care in promoting adherence (Allen et al., 2011; 
Kekwaletswe & Morojete, 2014). 
 
Limitations 
 One of the major limitations of this study was that the instrument used to measure 
adherence to ART was based on self-reported information and collected by interviewers 
at the GHESKIO Center. It is possible that participants provided responses that they 
thought were appropriate and/or wanted to please the interviewers. Other methods could 
have been used to indirectly measure adherence to medication within the sample 
population by viral load testing, which is very sensitive, particularly in the short term, to 
adherence recommended by the WHO (WHO, 2003). Other more direct method could be 
a time-sensitive pill count as well as electronic bottle-caps that record use, Medication 
Event Monitoring Systems (MEMS) (Parienti et al., 2001). These methods may have 
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yielded more accurate results among the population (Malow et al., 2013). Another 
general limitation is that all other measures used in this study were self-reported, though 
in general, such instruments have been reliable, especially among individuals in poor-
resource settings.  
Gathering a representative sample is vital to sound research. Analyses were also 
limited by sample size and sampling method. Convenience sampling does not ensure that 
the sample is representative of the population (Trochim, 2005). The sample of HIV-
positive female Haitian alcohol users for this study was composed of women who were 
attending the GHESKIO center and seeking HIV care and management. Results from this 
study may not be generalized to the total female Haitian population as the sample may 
not have been representative. The sample was further limited by incomplete data on 
individual instruments.  
Another limitation of the current study that merits more research is the issue of 
examining participants’ responses for some of the variables at one point in time. In 
addition, due to the relatively short length of the intervention, it is possible that more 
changes could have been observed at 3, 6 months and 12 months post-intervention. 
Additionally, this study was limited to females’ current psychological and social factors, 
which excluded their family and sexual history; these factors may have added more to the 
findings. Furthermore, discussion with participants, as they navigate and deal with 
treatment and management, how they acquired the disease and the amount of time since 
diagnosis would be valuable; these variables would have provided information regarding 
attitude and beliefs about their HIV status and willingness to enhance their health. 
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Finally, the fact that the results did not link psychological factors and adherence 
to ART could indicate that TPA/TPB was not the best theoretical model to predict 
adherence in the sample population. It is also possible that findings were not predictive of 
the variance in adherence because there were confounding variables that were not 
studied. For example, partner conflict and sexual violence were not examined in this 
study and could have provided additional information regarding barriers to adherence 
within the sample population. Although perceived social support was examined in this 
study, it mainly focused on financial and emotional support obtained from close family 
members and friends. Other factors, such as familial responsibilities, participants who are 
mothers and have children to take care of, and other responsibilities were not examined, 
and could have added to the reasons for non-adherence among the population.  
 
Recommendations  
 The findings provided in the current study may provide a valuable contribution to 
the development of intervention programs among persons living with HIV/AIDS, 
especially among females in poor-resource settings. Haiti, which now has the second 
highest rate of HIV/AIDS in the Western Hemisphere, is still coping with the 
repercussions of the 2010 earthquake. Many individuals living in Haiti are now living 
with post-traumatic stress disorder, in addition to other mental health disorders which 
often go untreated and undiagnosed (Raviola et al., 2012). Assessing participants’ mental 
status using an effective diagnostic method before introducing an intervention program is 
a valuable research opportunity. The WHO issued a call to action and proposed integrated 
mental health issues in intervention programs, especially in poor-resource settings 
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significantly impacted by the HIV/AIDS epidemic. This recommendation has particular 
relevance for Haiti (Bass et al., 2012) and more specifically among female alcohol users. 
Additionally, recommendations that interventions be focused on nutrition support and 
education should be prioritized for PLWH in Haiti and similar resource-poor settings 
(Palar et al., 2014). 
Since adherence did not increase in this sample, the findings suggest that 
additional supportive and psychological services may be needed in order to promote 
higher adherence to ART among HIV-positive female women in third world countries 
devastated by the impact of HIV/AIDS. In addition, although neither depression nor 
anxiety were related to adherence, depression decreased in the intervention group, which 
is a positive finding in and of itself. Conversely, because of the limitations of self-
reporting, especially in the clinic and/or to clinic staff, it is helpful to indirectly measure 
adherence by measuring viral load; in the end, the important outcome is viral load not 
adherence. 
 Beyond improving stress management skills to enhance adherence, there is an 
opportunity for improving interventions aimed at increasing support. An intervention that 
addresses support needs such as peer support and support from health care professionals 
could improve adherence to ART (Martinez et al., 2014; Palar et al., 2014). Allocating 
research funds to discovering significant factors affecting barriers to adherence among 
women, especially in the Caribbean and poor-resource settings, will lead to more 
effective interventions among this understudied population. Among the most promising 
such interventions are approaches that address the isolation, need for secrecy and chaotic 
lives that many underserved women endure including accompaniment (Behforouz et al., 
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2004) and mobile text messages to remind patients to take their medication (Horvath et 
al., 2012). Both simplification of regimens so that there are no requirements for taking 
medications with food (Kalichman et al., 2015) and addressing food insecurity (Martinez 
et al., 2014) may be effective  in addressing common problems with adherence in Haitian 
women. Eventually, effective interventions addressing mental health issues, particularly 
depression, anxiety and belief about medicine, in addition to providing peer and structural 
support could guide the development of programs that would enhance adherence.  
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APPENDIX 
ACRONYMS AND ABBREVIATIONS 
 
AOD      Alcohol or Other Drug  
ART     Antiretroviral Therapy  
CBSM     Cognitive Behavioral Stress Management 
CBSM-A    Cognitive Behavioral Stress Management-Adapted 
GHESKIO  Groupe Haitien d’Etude du Sarcome de Kaposi et 
des Infections Opportunistes  
 
HDI      Human Development Index  
IMB     Information, Motivation, Behavior 
NIAAA     National Institute of Alcohol Abuse and Alcoholism 
NIH      National Institutes of Health  
PLWH     People Living with HIV 
TPB/TRA    Theory of Planned Behavior/Reasoned action 
 
 
 
 
 
 
 
 
 
 115 
 
VITA 
 
PASCALE CECILE JEAN 
  
 
December 1999  Bachelor of Science, Dietetic and Nutrition 
    Florida International University  
    Miami, Florida  
 
August 2001 Masters of Public Health, Health Promotion and Disease 
Prevention 
    Florida International University  
    Miami, Florida  
 
August 2001- April 2002 Dietetic Internship  
    Pasco County Health Department Dietetic Internship 
    Miami, Florida  
 
2006 – 2015   Doctoral Candidate in Public Health  
    Florida International University  
    Miami, Florida     
  
     
PUBLICATION AND PRESENTATION 
 
Catherwood, A.S., Jean, P.C., Pelletier, V., Jean-Gilles, M., Rosenberg, R., Dévieux, 
J.G., Malow, R. (2009, November). Relationships between educational attitudes, 
parental caring, parental communication and risk behavior among Haitian adolescents 
in Miami-Dade County. Poster presented at the American Public Health Association 137th 
Annual Meeting, Philadelphia, PA. 
 
 
